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Problem: This thesis summarizes the existing literature on early rehabilitation in the intensive care unit 
(ICU) (Aim 1); conducts two studies evaluating the epidemiology of psychiatric symptoms among 
survivors of critical illness (2); and evaluates implementation of two different evidence-based 
interventions (rehabilitation interventions (early mobilization and cognitive stimulation)) as part of usual 
care to improve ICU-acquired physical and neuropsychological complications (3). 
Methods: Aim 1 – Narrative review of the literature on early rehabilitation in the ICU to improve 
physical and mental health outcomes. 2a –Meta-analysis evaluating posttraumatic stress disorder (PTSD) 
symptoms in ICU survivors. 2b - Prospective longitudinal cohort study evaluating prevalence and co-
occurrence of psychiatric symptoms among acute respiratory distress syndrome (ARDS) survivors. 3a - 
Pre-post evaluation of the sustainability of structured quality improvement (QI) project focused on early 
mobilization in medical ICU. 3b – Qualitative evaluation of barriers and facilitators to implementing 
cognitive stimulation, as part of a usual care, in an ICU. 
Results: Aim 1 - Early rehabilitation interventions targeting physical impairments in the ICU may be 
effective. 2a – The search identified 28 articles (3,428 patients). Between 1-6 months post-ICU (6 
studies; n=456), the pooled prevalence of clinically important PTSD symptoms [95% CI] was 25% [18-
34%]. 2b - During 12 months, 416 (66%) of 629 patients with ≥1 psychiatric outcome measure had 
substantial symptoms in ≥1 domain. The most common pattern of co-occurrence was having symptoms 
of all 3 psychiatric domains. 3a - More patients post-QI versus pre-QI were able to 
stand/transfer/ambulate in the ICU (64% vs. 7%, p<0.001). Among post-QI versus pre-QI patients, there 
was a shorter median [IQR] time to first physical therapy (4 [2,6] vs. 11 days [6,29], p<0.001), which was 
sustained over the 5 years during the post-QI period. 3b - Twenty-three MICU nurses identified 12 
barrier and 9 facilitator themes corresponding to the each of the Consolidated Framework for 
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Implementation Research domains. Patient-specific variables (e.g. sedation) were most frequently 
reported.  
Conclusions: Impairments in mental health and physical function are common among survivors of 
critical illness. The use of structured quality improvement processes can contribute to sustained 
implementation of evidence-based interventions in the ICU. 
 
Dissertation Readers: Dale M. Needham, MD, PhD; Franklin Adkinson, MD; O. Joseph Bienvenu, MD, 
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CHAPTER 1: INTRODUCTION 
As the population ages, a growing number of Americans are requiring critical care, including mechanical 
ventilation for acute respiratory failure.1 At the same time, improvements in the management of 
critically ill patients have resulted in decreased mortality.2 Hence, there is a growing population of 
survivors of critical illness who experience long-term complications in physical function, mental health, 
and cognition. Collectively, these impairments are termed the “Post-Intensive Care Syndrome” (PICS).3 
Post-Intensive Care Syndrome 
These impairments in physical, cognitive, and mental health status are associated with worse health-
related quality of life and can persist for years after discharge from the intensive care unit (ICU).3,4 
Prolonged bedrest and immobilization during critically illness can lead to neuromuscular weakness and 
impaired physical function.5 More than half of survivors of critical illness will have impairments in 
activities of daily living (ADLs) at one year after discharge, while among those who require mechanical 
ventilation, nearly 70% will have substantial impairments in ADLs.6,7 Moreover, studies evaluating 
patients who were relatively young and had few pre-ICU comorbidities reported that 50% had not 
returned to work at a year post-ICU discharge, and the majority reported muscle weakness as a major 
contributor to their inability to return to work.5,8 
Survivors of critical illness similarly experience substantial impairments in mental health, including 
depression, anxiety and posttraumatic stress disorder (PTSD) symptoms. Approximately one-third of 
critical illness survivors will experience substantial depressive symptoms over the year following 
discharge from the ICU,9 with a similar number being affected by anxiety symptoms.10 In a prospective, 
longitudinal study of acute respiratory failure survivors, one-third developed PTSD symptoms over the 
two years following ICU discharge.11 
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Finally, survivors of critical illness also have considerable impairments in cognition that persist well 
beyond the acute hospitalization. In a study of 821 critically ill patients, 75% of whom were delirious 
during the hospital stay, one-third had scores on cognitive testing that were consistent with moderate 
traumatic brain injury while one quarter had scores consistent with mild Alzheimer’s Disease at one year 
follow-up.12 Notably, this cognitive impairment affected not just older, more vulnerable patients, but 
young patients as well. Importantly, a longer duration of delirium in the ICU was associated with worse 
cognitive impairment at one-year follow-up.12 
There are currently few evidence-based methods for the prevention or treatment of long-term 
complications after critical illness. Notably, early mobilization and physical rehabilitation in the first 48 
hours of admission to the intensive care unit has been associated with improved strength, physical 
function and quality of life.13-15 Similarly, cognitive stimulation in the intensive care unit has been shown 
to decrease the incidence and duration of delirium, which is an important risk factor for long-term 
cognitive impairment.16,17  
Thesis Aims 
This thesis aims to evaluate the prevalence of, and risk factors for, complications of critical illness and to 
evaluate interventions focused on preventing and treating such impairments, as follows: 
1) Synthesize the existing literature on early rehabilitation in the intensive care unit with a goal of 
reducing physical and mental health impairments in survivors. (Parker et al., Curr Phys Med Rehabil 
Reports. 2013) 
 
2) Describe the prevalence of psychiatric symptoms in survivors of critical illness, via the following: 
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a. Determine the prevalence of PTSD symptoms after critical illness and summarize associated 
risk factors via a systematic review and meta-analysis of the existing literature. (Parker et al., 
CCM, 2015) 
b. Evaluate the prevalence and co-occurrence of, and risk factors for, depression, anxiety and 
PTSD symptoms in the year following acute respiratory distress syndrome. (Huang, M., 
Parker, AM, et al., CCM, 2016) 
 
3) Evaluate the implementation, in routine clinical practice, of evidence-based interventions designed 
to reduce immobility and delirium in the intensive care unit, as follows: 
a. Evaluate the sustained effect of a quality improvement project on the early initiation of 
physical therapy interventions in the intensive care unit. (Dinglas VD & Parker AM (co-first 
authors), et al., Annals ATS, 2014) 
b. To understand perceived barriers to implementing a cognitive stimulation intervention via 
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Survivors of critical illness often experience new or worsening impairments in physical, cognitive and/or 
mental health, referred to as post-intensive care syndrome (PICS). Such impairments can be long-lasting 
and negatively impact survivors’ quality of life. Early rehabilitation in the intensive care unit (ICU), while 
patients remain on life-support therapies, may reduce the complications associated with PICS. This 
article addresses evidence-based rehabilitation interventions to reduce the physical and mental health 
impairments associated with PICS. Implementation of effective early rehabilitation interventions 
targeting physical impairments requires consideration of 5 factors: barriers, benefits, feasibility, safety, 
and resources. Mental health impairments may be addressed by the following interventions: ICU diaries, 
early in-ICU psychological intervention, and post-ICU coping skills training. In both cases, a 
multidisciplinary team-based approach is paramount to the successful incorporation of early 
















The term Post-Intensive Care Syndrome (PICS) refers to new or worsening impairments in physical, 
cognitive and/or mental health in ICU survivors [1]. These morbidities persist beyond the acute care 
hospitalization and can be long-lasting, negatively impacting quality of life [1-3]. This review focuses on 
new research evaluating evidence-based rehabilitation interventions to reduce the physical and mental 
health impairments associated with PICS.  
 
Critically ill patients are often exposed to prolonged immobilization, which can lead to neuromuscular 
weakness and subsequent impairments in physical function lasting for months to years after discharge 
from the intensive care unit (ICU) [4-6]. For instance, almost all ICU survivors have decrements in 
performing activities of daily living a year after discharge, and neuromuscular abnormalities persist for 
up to 5 years in 84% to 95% of ICU survivors with critical illness polyneuropathy [2, 5]. Additionally, 
survivors of critical illness are at risk for mental health problems, including anxiety, depression and post-
traumatic stress disorder (PTSD) [7-10].  The median prevalence for clinically important anxiety and 
depression symptoms in ICU survivors is 24% and 28%, respectively [7, 11], and one-third of patients 
develop PTSD symptoms in the first 2 years following critical illness [12]. 
 
Early rehabilitation is essential to reducing complications associated with PICS [1, 13-15]. “Early” refers 
to rehabilitation interventions that commence immediately after stabilization of physiologic 
derangements, often while patients remain on mechanical ventilation and vasopressor infusions [1, 15-
18]. A shift in ICU “culture” with a focus on interventions to reduce subsequent physical and mental 





Early Rehabilitation for Neuromuscular Weakness 
Implementation of an early rehabilitation program, incorporating physical and occupational therapy, 
requires consideration of potential barriers, feasibility, benefits to be achieved, safety, and necessary 
resources, as described below [16]. Further information and support for ICU-based rehabilitation can be 
found via an international Mobilization Network (www.mobilization-network.org). 
 
Potential Barriers to Rehabilitation in the Critically Ill patients 
Inadequate multidisciplinary staffing and collaboration, deep sedation and a lack of knowledge 
regarding benefits to patients are among the most important potential barriers to successful 
implementation of early rehabilitation programs [20-24]. In a prospective observational study in the ICU, 
rehabilitation therapy was not provided for a median [Interquartile Range (IQR)] of 56% [25%-68%] of 
ICU days per patient due to limited availability of rehabilitation staff [22]. A subsequent quality 
improvement project at Johns Hopkins Hospital, including dedication of a full-time physical therapist and 
occupational therapist to this ICU, resulted in an increase in rehabilitation sessions and improved 
physical function among mechanically ventilated patients [25]. This quality improvement project also 
incorporated multidisciplinary education for all members of the ICU and rehabilitation team to address 
potential gaps in knowledge. 
 
Deep sedation can also limit patient participation in early rehabilitation [20, 22, 25]. The observational 
pilot study, mentioned above, reported that mechanically ventilated patients were ineligible for 
rehabilitation therapy for a median [IQR] of 27% [15%-61%] of ICU days per patient due to sedation 
and/or non-responsiveness [22]. In a pre-post study of 104 patients requiring mechanical ventilation > 4 
days, the absence of sedatives was predictive of increased ambulation (OR 1.90; 95% CI 1.19-3.15, 
p=0.009) [19]. Moreover, analyses of a prospective cohort of >500 patients revealed that continuous 
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sedative infusion was associated with longer time to first physical and first occupational therapy 
sessions [23, 26]. Evidence-based protocols to limit sedation and facilitate weaning from mechanical 
ventilation [27-30]  are advocated to assist with early rehabilitation [31].  
 
Feasibility 
An ICU “culture” supporting quality improvement and evidence-based rehabilitation interventions is 
essential to a successful early rehabilitation program [16, 20]. In addition to the barriers mentioned 
above, rehabilitation therapy in the ICU can be limited by patient availability due to diagnostic testing 
and therapeutic procedures. Multidisciplinary collaboration may help ensure patient availability, 
adequate staffing and the coordination needed to achieve early rehabilitation in the busy ICU 
environment. As described below, such collaboration may be solidified through development of ICU-
specific protocols and order-sets to enhance the delivery of early rehabilitation programs [29, 32, 33].  
 
A pre-post study of patients mechanically ventilated > 4 days demonstrated that intra-hospital transfer 
from a traditional ICU to a Respiratory ICU, where active mobilization is a priority, was associated with 
increased patient ambulation [20] (odds ratio (OR) 2.47, p<0.001) [19]. This change was not explained by 
improved physiologic status, but attributed to the “culture” and multidisciplinary focus on early 
mobilization in the Respiratory ICU. Nursing and rehabilitation staffing was identical between the 
traditional ICU and Respiratory ICU, demonstrating the value of a collaborative “culture” supporting 
rehabilitation practices. This “culture of mobility”  promotes prioritization of early rehabilitation as 
routine care for the eligible patients through multidisciplinary education and engagement [34]. 
 
Protocols and order sets may improve the effectiveness of an early rehabilitation program. In a 
prospective trial, 330 patients were assigned to either usual care or early physical therapy delivered 
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according to a protocol by an ICU Mobility Team, consisting of a critical care nurse, physical therapist, 
and nursing assistant [35]. The mobility protocol included an automatic physician order for physical 
therapy rather than a physician-determined manual order. A greater proportion of patients in the 
protocol versus usual care group participated in at least one physical therapy session during their 
hospital stay (80% versus 47%, p≤0.001). Of those receiving physical therapy, more patients in the 
protocol versus usual care group had treatment initiated while in the ICU (91% versus 13%, p≤0.001).  
 
The usefulness of a nurse-driven mobility protocol and computerized order set was evaluated in a pre-
post evaluation including ICU and intermediate care patients [32]. The proportion of ICU and 
intermediate care patients ambulating within 72 hours of admission increased by 14% and 56%, 
respectively, after the protocol was initiated (p<0.001). Moreover, a quality-improvement project 
including 100 consecutive patients in a surgical ICU (SICU) evaluated the mandatory entry of 
computerized mobility orders as well as a mobility protocol for nurses [33]. The protocol included 
physiologic criteria for patient screening with re-evaluation of ineligible patients every 6 hours until 
eligible or transferred out of the unit. The proportion of patients with mobility orders and mobilized 
increased after the intervention (82% versus 58%, p<0.05 and 80% versus 22%, p<0.05, respectively). 
Finally, a clinical trial involving 193 patients assigned to either usual care or protocol-driven 
physiotherapy in a SICU reported a greater proportion of therapy sessions involved mobility in the 
protocol versus usual care group (82% versus 66%, p<0.001) [36]. Thus, a change in “culture”, enhanced 






Potential benefits for patients participating in early rehabilitation in the ICU include improved muscle 
strength, physical function and quality of life [6, 13, 14, 37]. Additionally, early rehabilitation programs 
may be associated with reduced hospital and ICU length of stay (LOS), duration of mechanical ventilation 
and hospital costs [6, 13, 14, 25, 37, 38]. 
 
Muscle Strength, Physical Function, and Quality of Life 
Early rehabilitation is associated with improved muscle strength, physical function and quality of life in 
ICU survivors. In three systematic reviews [13, 14, 37], ICU-based rehabilitation was associated with 
earlier achievement of mobility milestones[15, 19, 25, 35] and improved muscle strength [39, 40] 
including measures of respiratory, upper limb and/or lower limb strength. In one randomized controlled 
trial (RCT), supine cycle ergometry in mechanically ventilated patients was associated with improved 
physical function and quality of life [39].  
 
In an RCT of early physical and occupational therapy in 104 mechanically ventilated patients, ICU-
acquired weakness, as evaluated by manual muscle strength testing, occurred in 31% versus 49% of 
patients in the intervention versus control group (p=0.09) [15]. Additionally, the greatest unassisted 
walking distance at hospital discharge was longer in the intervention versus control group (median [IQR] 
33m [0-91m] versus 0m [0-30m], p=0.004). Finally, independent functional status at hospital discharge 
(the trial’s primary outcome) was achieved by a greater proportion of patients in the intervention group 
(59% versus 35%, p=0.02).  
 
Implementation of early rehabilitation, as a part of routine care in the ICU, has also demonstrated 
improved physical function. In a prospective observational evaluation involving 104 patients requiring 
mechanical ventilation >4 days in a Respiratory ICU, the average distance ambulated on the last day of 
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ICU stay was 238 feet, which is much greater than otherwise expected [19]. Likewise, a prospective 
quality improvement project was associated with an increase in the proportion of patients receiving 
rehabilitation interventions having a functional mobility level of sitting or greater (56% pre-intervention 
versus 78% post-intervention, p=0.03) [25]. 
 
Reduced Duration of Mechanical Ventilation, Length of Stay (LOS) and Costs 
Early rehabilitation may be associated with reduced healthcare costs resulting from a reduction in 
duration of mechanical ventilation, and ICU and hospital LOS [35, 37, 41, 42]. A significant reduction in 
the duration of mechanical ventilation has been reported in three studies [15, 40, 43]. One of these 
studies, an RCT of early physical and occupational therapy versus usual care, demonstrated a reduced 
median (IQR) duration of mechanical ventilation of 3.4 [2.3-7.3] versus 6.1 [4.0-9.6] days (p=0.02), and a 
reduced median (IQR) ICU LOS (5.9 [4.5–13.2] versus 7.9 [6.1–12.9] days, p=0.08) [15].  
 
A medical ICU (MICU) quality improvement project, consisting of a multidisciplinary team approach to 
sedation and rehabilitation practices, was associated with a decrease in average ICU and hospital LOS of 
2.1 and 3.1 days, respectively, with a 20% increase in MICU admissions compared with the same period 
from the prior year [25].  
 
In a prospective trial of 330 MICU patients, early rehabilitation with a mobility protocol versus usual care 
was associated with a shorter adjusted ICU and hospital LOS (mean 5.5 versus 6.9 days, p=0.025 and 11 
versus 15 days, p=0.006, respectively) [35]. Moreover, the mean cost per patient was lower in the 
protocol versus usual care group ($41,142 versus $44,302). Total costs were also reduced in the protocol 
versus usual care group, even after accounting for the additional cost associated with implementing the 




A financial model, based on outcomes associated with implementation of an early rehabilitation 
program in the Johns Hopkins MICU as well as existing publications, projected a net financial savings in 
20 (83%) of 24 different scenarios with financial estimates ranging from $88,000 (net cost) to $3,763,000 
(net savings) from investment in an early rehabilitation program [42]. 
 
Safety 
Clinical trials as well as studies of routine clinical care have verified the safety of early rehabilitation in 
critically ill patients. In two systematic reviews, no serious adverse events resulting in death or near-
death were reported, with the most common potential adverse event being a transient decrease in 
oxygen saturation [13, 14]. Inadvertent removal of endotracheal tubes, vascular catheters or other 
support devices was rare. 
 
Observational Studies with Safety Data 
A prospective study of 31 patients participating in 69 mobilization sessions in a single ICU described the 
physiologic consequences of mobilizing critically ill patients [44]. The proportion of patients 
mechanically ventilated with a tracheostomy was 23% (7/31), and the remaining 24 patients were not 
mechanically ventilated. Activity levels consisted of sitting on the edge of the bed with progression to 
standing in place, transferring to a chair or ambulating. Heart rate and blood pressure significantly 
increased during rehabilitation interventions while there was a non-significant decrease in oxygen 
saturation. In only 3 of 69 sessions (4%), there was a decrease in oxygen saturation requiring a 
temporary increase in FiO2. Otherwise, no potential safety events required additional therapy, and no 
life-threatening adverse events occurred despite most of the sessions (91%) involving patients with 
limited cardiopulmonary reserve prior to mobilization. Similar findings were reported in a prospective 
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observational pilot study of early rehabilitation involving 19 mechanically ventilated patients in the 
Johns Hopkins MICU, in which heart rate, oxygen saturation, and blood pressure were monitored and 
recorded during 50 rehabilitation sessions [22]. There were only small and clinically inconsequential 
changes in these physiologic parameters. 
 
In a prospective, observational evaluation of 1,449 early rehabilitation activities in 103 patients requiring 
mechanical ventilation >4 days in a Respiratory ICU, adverse events were rare, occurring in only 14 
(<1%) activities [17]. Patients with an endotracheal tube participated in 593(41%) activity events, which 
ranged from sitting on the edge of a bed to ambulating. Potential safety events, which included fall (5 
occasions), systolic blood pressure <90 mmHg (4 occasions) or >200 mmHg (1 occasion), oxygen 
saturation <80% (3 occasions), and feeding tube removal (1 occasion), did not result in any additional 
therapy, LOS or healthcare costs. 
 
Clinical Trials with Safety Data 
Four clinical trials demonstrated the safety of early rehabilitation interventions in critically ill patients 
[15, 35, 36, 39]. In an RCT occurring in one MICU and one SICU at a single center, 90 patients were 
randomized to either standard rehabilitation therapy alone or standard therapy plus active training with 
a bedside lower extremity cycle ergometer [39]. Of the 90 patients, 84% were on mechanical ventilation 
at the time of trial enrollment. Physiologic changes prompted the cessation of activity in only 16 (4%) of 
425 sessions with the cycle ergometer, with resolution occurring within 2 minutes. There was one 
Achilles tendon rupture associated with cycling. 
 
In another RCT, 104 patients on mechanical ventilation via an endotracheal tube in 2 MICUs were 
assigned to either usual care or early physical and occupational therapy [15]. Serious adverse events, 
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defined as fall to knees, endotracheal tube removal, systolic blood pressure >200 or <90 mm Hg, and 
desaturation to <80%, occurred in only 1 of 498 (0.2%) sessions. This single event was oxygen 
desaturation. Physiologic derangements, most commonly perceived patient-ventilator asynchrony, 
resulted in the premature discontinuation of therapy in only 4% of all sessions. Inadvertent removal of 
tubes and lines was also recorded, revealing the removal of a single radial arterial catheter. No falls or 
unplanned endotracheal tube removal were reported.   
 
In another trial, 330 patients mechanically ventilated via an endotracheal tube were assigned to either 
usual care or protocol-driven early physical therapy with an ICU Mobility Team [35]. Of the 145 patients 
assigned to the intervention group, 73% participated in at least one physical therapy session while in the 
ICU. There were no deaths, near-deaths or cardiopulmonary resuscitation during physical therapy 
sessions. There were no potential safety events such as accidental removal of a device.  Patient fatigue 
was the most common reason for ending a mobility session, without any clinically important change in 
physiologic parameters.  
 
In a fourth trial, 163 patients in a SICU received physical therapy according to usual care or a 
physiotherapy protocol [36]. Protocol patients participated in a total of 615 treatment sessions, with 5 
adverse events occurring in 4 sessions. These events included hemodynamic instability (2 events), 
unintentional removal of a peripheral intravenous catheter (2 events), and fall to knees (1 event).  
 
Rehabilitation with Central Venous and Arterial Catheters 
Several studies have demonstrated the safety of early rehabilitation in patients with central venous and 
arterial catheters [18, 45, 46]. In a retrospective case-series, 30 patients in a cardiovascular ICU (CVICU) 
participated in 156 activity events ranging from sitting to walking with a femoral arterial catheter in 
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place, with no catheter-related adverse events occurring as a result of physical therapy [45]. In a 
prospective study, 77 CVICU patients with a femoral catheter participated in 210 physical therapy 
sessions encompassing 630 mobility activities [47]. The following catheter-related events were 
evaluated: bleeding, hematoma, line dislodgement, nonfunctioning catheter or a change in vascular 
status, with no events (0% event rate) occurring during or immediately after any mobility activity.  
 
Another evaluation of 49 MICU patients participating in 183 physical therapy sessions while on 
mechanical ventilation with a central venous and 115 sessions with an arterial catheter in place, 
reported inadvertent removal of only 1 arterial and 0 central venous catheters [18]. In this study, the 
internal jugular vein was the most common venous catheter site (43% of catheter-days), followed by 
subclavian (29%) and femoral (10%) veins, and in 47% of sessions, an arterial catheter was present. Of all 
sessions taking place, continuous hemodialysis and at least one vasopressor infusion was present during 
9% and 17%, respectively. Similarly, in a prospective study of 109 patients receiving continuous 
hemodialysis, 104 (95%) underwent mobility within 48 hours of starting continuous hemodialysis [48]. 
There were no life-threatening events associated with mobility, and the only potential safety event was 
one temporary disconnection from the circuit. Patients with jugular and femoral access participated in 
mobility, but patients with jugular access were more likely to progress to more advanced mobility 
interventions. 
 
A larger prospective evaluation conducted in the Johns Hopkins MICU evaluated 101 consecutive 
patients who underwent 253 physical therapy sessions with a femoral catheter in situ, most commonly 
venous catheters, which accounted for 71% of patient days with physical therapy [46]. No femoral 
catheter-related adverse events occurred during rehabilitation activities (event rate: 0%; upper 95% 
confidence bound: 1.4%). Femoral catheter-related events were defined as: non-functioning catheter, 
18 
 
removal of catheter, bleeding at catheter site, catheter line-associated blood stream infection, 
retroperitoneal hematoma, and limb ischemia. The highest activity levels in physical therapy sessions 
conducted with a femoral catheter in situ were in-bed exercises (38%), sitting (27%), standing/walking 
(23%), and supine cycle ergometry (12%).  
 
Screening for Patient Safety 
Clinical judgment to assess patient appropriateness for active mobilization is important for safely 
implementing an early rehabilitation program in the ICU. Multidisciplinary collaboration can augment 
the decision-making process. An algorithm can be useful to screen patients for stability prior to initiation 
of physical or occupational therapy interventions [16, 44]. 
 
Resources for Early Rehabilitation in the ICU 
General Resources 
Contributions from all members of the multidisciplinary team are important for the successful 
implementation of early rehabilitation in an ICU [16, 20, 23, 25]. Additionally, a medical director may 
advocate for the appropriate allocation of staff, resources and equipment to ensure that all eligible 
patients are able to safely engage in rehabilitation activities [25]. 
 
Critically ill patients are often tethered to various medical devices via lines and tubes, making 
mobilization, and especially ambulation, challenging. Trained staff and assistive equipment can improve 
the safety and efficiency of ambulating critically ill patients [16]. A rolling IV pole allows transport of 
infusing medications. Additionally, ambulating with mechanically ventilated patients necessitates either 
a battery-powered standard ventilator, portable ventilator or Ambu bag with an oxygen source. Finally, 
patients may require use of a walker and wheelchair for support and for a seated rest break. Moreover, 
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cardiac and oxygen saturation monitors are generally used. A mobility aid, which consolidates all of the 
necessary equipment into one portable device, has been used in the Johns Hopkins MICU and elsewhere 
to help simplify patient ambulation and reduce staffing needs [32, 49]. 
  
Neuromuscular Electrical Stimulation 
Neuromuscular electrical stimulation (NMES) induces passive muscle contraction in targeted muscle 
groups via skin electrodes. Several Phase II clinical trials of NMES in ICU populations show favorable 
initial results. One clinical trial, which randomly assigned 46 patients mechanically ventilated <7 days or 
>2 weeks to NMES versus sham, found that patients on mechanical ventilation >2 weeks who received 
NMES had a greater improvement in quadriceps muscle thickness (+4.9% versus -3.2%, p=0.013) [50]. In 
another clinical trial of 140 critically ill, mostly (97%) requiring mechanical ventilation, daily NMES versus 
usual care was associated with a lower incidence of ICU-acquired weakness in the 52 patients who could 
be evaluated for this outcome (13% versus 39%, p=0.04) [40]. Conflicting results were presented by two 
small RCTs of patients with septic shock, in which NMES was applied to one leg of each patient with the 
contralateral limb serving as a control. In the first trial, involving 8 patients, the quadriceps muscle 
volume between groups was similar at 7 days [51]. In the other trial, 16 patients were randomized for 13 
days, and quadriceps and biceps strength were greater in the group receiving NMES at 13 days (p=0.034 
and p=0.005 respectively) [52]. Patients with greater baseline weakness showed the most improvement. 
 
Cycle Ergometer 
A bedside ergometer is a stationary cycling device that allows for passive or active cycling with 
increasing levels of resistance. In an RCT of 90 critically ill patients, those assigned to standard physical 
therapy plus cycling exercises versus standard therapy alone demonstrated greater improvement in 
muscle strength, physical function, and quality of life at hospital discharge [39]. Patients in the 
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intervention group cycled passively (if sedated or nonresponsive) or actively 20 minutes per day, five 
days per week. In the intervention group, the proportion of patients actively cycling increased from 45% 
to 87% from the first to the final cycling session before ICU discharge. At hospital discharge, patients in 
the intervention versus control group had a greater 6 minute walk distance (median [IQR] 196m [126–
329m] versus 143m [37–226m], p<0.05), quadriceps muscle force (2.4±0.6N·kg-1versus 2.0± 0.8N·kg-1, 
p<0.05) and quality of life, (SF-36 Physical Function domain score:  median [IQR] 21 [18–23] versus 15 
[14–23], p<0.01). 
 
Early Rehabilitation for Mental Health Impairments 
Interventions to reduce the mental health impairments associated with PICS have received relatively 
less research than interventions focusing on the physical aspects of recovery. However, there are three 
interventions that show promising results: ICU diaries, early in-ICU psychological intervention, and out-
patient telephone-based coping skills intervention [53-56]. 
 
ICU Diaries 
Three studies, including two RCTs, support the use of ICU diaries to reduce mental health complications, 
such as anxiety, depression and PTSD in ICU survivors [54, 55, 57]. In one multicenter RCT conducted in 
12 ICUs at 6 general district hospitals and 6 university hospitals, medical staff and family kept a daily 
diary, including both pictures and text, for each patient during the ICU stay [55]. At one month follow-up 
after ICU discharge, 352 patients who were mechanically ventilated while in the ICU were randomized to 
receive their diaries as soon as desired (intervention) versus at 3 months (control). In the intervention 
group, 87% of patients received their diary at randomization, with the remainder receiving the diary 
within the following month. Intervention group patients reported reading the diary a median [IQR] of 3 
times [0-20]. At 3 month follow-up, fewer patients in the intervention versus control group had new-
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onset PTSD (5% versus 13%, p=0.02), with patients having the greatest PTSD symptoms at 1 month 
having the greatest benefit of the diary intervention. Another RCT evaluated 36 patients in a single 
medical-surgical ICU [54]. Patients were assessed for symptoms of anxiety and depression on average 1 
month post-ICU discharge and 3 weeks later. Patients in the intervention group received their ICU diary 
at the first assessment. Anxiety and depression symptoms decreased significantly (p<0.05 and p<0.005, 
respectively) in the intervention group from the first assessment to the second, while scores remained 
the same in the control group.  
 
A prospective pre-post trial evaluated mental health symptoms at 3 and 12 month follow-up in 143 
patients who were assigned to either an ICU diary group or control group [58]. A total of 49 patients 
were assigned to the intervention group and received their diary at hospital discharge. At 3 month 
follow-up, there was no significant difference between groups with regard to anxiety and depression, 
but at 12 months, patients in the intervention versus control group had less PTSD symptoms ( Impact of 
Events Scale – Revised score:  mean (SD) 32.1 (15.4) versus 21.0 (12.2), p=0.004). Hence, clinical 
research supports the use of simple and inexpensive ICU diaries to reduce mental health complications 
associated with ICU survivorship.  An international ICU Diary Network (www.icu-diary.org) is available to 
assist and support use of ICU diaries. 
 
Early In-ICU Psychological Intervention 
A pre-post study of 209 patients admitted to a trauma ICU in Italy evaluated the mental health 
outcomes, at 12 month follow-up, of an in-ICU psychological intervention (delivered as part of routine 
care  - the “post” period) versus usual care that did not include a psychologist in the ICU (the “pre” 
period) [53].  In the post- versus pre-psychologist period, the proportion of patients with clinically 
important PTSD symptoms at 12 months after ICU discharge was lower (21% versus 57%, p<0.001), with 
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similar non-significant trends observed for anxiety and depression symptoms (9% versus 17%, p=0.088 
and 7% versus 13%, p=0.145, respectively). In this study, the psychologist performed a range of 
interventions in the ICU, including providing education, counseling, stress management, psychological 
support and coping strategies.  
 
Post-discharge Coping Skills Intervention 
Adaptive coping skills training is an evidence-based method for reducing symptoms of anxiety and PTSD 
in non-ICU patient populations [59, 60], and there is interest in evaluating this intervention in ICU 
patients [56]. One prospective pilot study (n=7) evaluated the association between a 12 session post-
discharge, telephone-based coping skills intervention and mental health symptoms in acute respiratory 
distress syndrome survivors [56]. The number of patients with clinically important PTSD symptoms 
decreased from 5 patients at enrollment to 1 patient after the intervention was complete. Additionally, 
depression and anxiety symptoms decreased following the intervention (Hospital Anxiety and 
Depression (HAD) sub-scale scores:  depression 11.2 versus 7.3, and anxiety 12.2 versus 6.2). Further 
research is needed to clarify the role of coping skills in mental health recovery for ICU survivors. 
 
Conclusion 
Early rehabilitation interventions in the ICU may reduce physical and mental health complications 
frequently occurring in survivors of critical illness. Potential benefits associated with early physical 
rehabilitation include improved muscle strength, physical function and quality of life, as well as reduced 
healthcare costs and LOS. Such ICU-based rehabilitation interventions are safe and feasible when 
conducted in the context of a multidisciplinary team approach.  ICU diaries, along with other ICU-based 
and out-patient psychological interventions, are worthy of consideration as means of reducing the 
burden of mental health complications after critical illness. Ongoing evaluation and implementation of 
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early rehabilitation programs for critically ill patients should be considered to address the common and 
long-lasting impairments associated with post-intensive care syndrome. 
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OBJECTIVE: To conduct a systematic review and meta-analysis of the prevalence, risk factors, and 
prevention/treatment strategies for post-traumatic stress disorder (PTSD) symptoms in critical illness 
survivors. 
DATA SOURCES: PubMed, Embase, CINAHL, Psyc INFO, and Cochrane Library from inception through 
March 5, 2014 
STUDY SELECTION:  Eligible studies met the following criteria: (1) adult general/non-specialty ICU, (2) 
validated PTSD instrument ≥1 month post-ICU, and (3) sample size ≥10 patients.  
DATA EXTRACTION: Duplicate independent review and data abstraction from all eligible 
titles/abstracts/full-text articles 
DATA SYNTHESIS: The search identified 3,243 titles/abstracts, with 28 eligible articles on 25 unique 
cohorts (n=3,428 patients). The Impact of Events Scale (IES) was the most common PTSD instrument. 
Between 1-6 months post-ICU (6 studies; n=456), the pooled mean [95% CI] IES score was 20 [17-24], 
and the pooled prevalences of clinically important PTSD symptoms [95% CI] were 25% [18-34%] and 44% 
[36-52%] using IES thresholds ≥35 and ≥20, respectively. Between 7-12 months post-ICU (5 studies; 
n=698), the pooled mean IES score was 17 [9-24], and pooled prevalences of PTSD symptoms were 17% 
[10-26%] and 34% [22-50%], respectively. ICU risk factors for PTSD symptoms included benzodiazepine 
administration, mechanical ventilation, and post-ICU memories of frightening ICU experiences. PTSD 
symptoms were associated with worse quality of life. In European-based studies: (1) an ICU diary was 
associated with a significant reduction in PTSD symptoms, (2) a self-help rehabilitation manual was 
associated with significant PTSD symptom reduction at 2 months, but not 6 months; and (3) a nurse-led 
ICU follow-up clinic did not reduce PTSD symptoms. 
CONCLUSIONS: Clinically important PTSD symptoms occurred in 1/4 of critical illness survivors at 1-year 
follow-up, with higher prevalence in those who had comorbid psychopathology, received 
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benzodiazepines, and had early memories of frightening ICU experiences. In European studies, ICU 






As mortality from critical illness decreases, there is an ever-growing population of critical illness 
survivors who frequently experience long-lasting physical, cognitive and mental health impairments.1-5 
Posttraumatic stress disorder (PTSD) is one important mental health impairment related to life-
threatening ICU experiences. According to the Diagnostic and Statistical Manual of Mental Disorders 5, 
PTSD can be diagnosed if an individual is exposed to actual or threatened serious injury/death (e.g. 
critical illness and related intensive care unit (ICU) treatments) and subsequently develops the following 
symptoms which last >1 month and cause significant distress or changes in functionality: persistently re-
experiencing the event and attempting to avoid trauma-related stimuli; new negative alterations in 
mood/cognition; and new/increased arousal/reactivity. Prior systematic reviews reported substantial 
PTSD symptoms occurred in 5 to 63% of critical illness survivors and were associated with worse health-
related quality of life.6-9 Previously described risk factors for PTSD include younger age, sedation with 
benzodiazepines, and recall of frightening ICU experiences.6-8 PTSD in the general population is 
associated with greater physical disability.10-12   
The burden of PTSD symptoms in critical illness survivors has gained increasing recognition in 
the past 5 years, with the number of studies published on this topic more than doubling compared with 
the preceding 5 year interval.7 Moreover, there is increasing homogeneity between studies regarding 
the instruments used for and timing of PTSD symptom assessment post-ICU. Such consistencies in study 
design provide new opportunities for pooling data on prevalence and severity of PTSD symptoms across 
studies. In addition, over the past 5 years, evidence has emerged regarding interventions for prevention 
and treatment of PTSD symptoms in critical illness survivors.13,14 
 Given this background, our objectives were to evaluate the prevalence of PTSD symptoms in 
general critical illness survivors via meta-analysis, and to perform a systematic review of the literature to 
synthesize the following: 1) patient-specific and ICU-related risk factors for PTSD symptoms; 2) 
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associations between PTSD and health-related quality of life (HRQOL); and 3) effectiveness of prevention 
and treatment interventions for PTSD symptoms. 
Materials and Methods 
Search strategy 
 We searched 5 electronic databases (PubMed, Embase, CINAHL, Psyc INFO, Cochrane Library) 
from inception through March 5, 2014 to identify eligible studies (Figure 1). We combined controlled 
vocabulary (MeSH and Emtree) and keyword terms and phrases to define the concepts of posttraumatic 
stress disorder, psychometrics, critical care and respiratory distress. These terms were “exploded” when 
applicable. The search strategy was not limited by language of publication. Detailed search strategies for 
each database are presented in Appendix – Search Strategy. A manual search of the reference lists from 
all relevant review articles was performed.  
Study selection 
For inclusion in the systematic review, articles were required to meet the following criteria: (1) 
study population consisting of adult critical illness survivors, (2) PTSD assessment conducted using a 
validated measure, and (3) PTSD assessment conducted ≥1 month post-ICU discharge while patients 
were in their home environment. Articles were excluded from the review if the study population met 
any of the following criteria: (1) >50% pediatric patients (<16 years), (2) <50% ICU patients, (3) primary 
focus on patients with a specific illness/disease or from a specialty ICU (e.g., trauma/burn unit, coronary 
or neurological ICU, etc.), or (4) case series with <10 patients. Abstracts, dissertations not published in a 
peer-reviewed journal, and review articles were excluded.  
Two reviewers independently and sequentially reviewed titles and abstracts, and then full text 
articles to select eligible studies. All selected titles and abstracts were included in the review of full text 
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articles. Any disagreement regarding eligibility of full text articles was resolved by consensus of all 
authors.  
Data abstraction  
 Two reviewers independently abstracted data from each eligible article, with any differences 
resolved by consensus among abstractors in consultation with an independent co-author (D.M.N). The 
following were abstracted from each eligible study:  design and population, baseline cohort 
characteristics, inclusion/exclusion criteria, proportion of patients with pre-existing psychiatric illness, 
timing of and sample size(s) at each PTSD assessment, PTSD assessment instrument (and scoring 
method), point prevalence of clinically important PTSD symptoms (i.e. PTSD symptom score above a pre-
defined threshold), potential PTSD risk factors, and associations between PTSD symptoms and HRQOL. 
Authors of eligible studies were contacted for additional information or clarifications, when necessary. 
Risk of Bias Assessment 
Risk of bias assessment for included studies was conducted using the Cochrane Risk of Bias15 for 
randomized controlled trials (RCTs) and the Newcastle Ottawa Scale16 for observational studies.  
Statistical Analysis 
The Impact of Event Scale (IES) was the most common instrument used for measuring PTSD 
symptoms. For studies using the IES, we abstracted the following data (or requested these data from 
study authors when not reported): 1) point prevalence of clinically important PTSD symptoms as 
indicated by an IES score ≥20 and ≥35 (most commonly used thresholds) and 2) mean (standard 
deviation) IES score. Given variability among studies in the timing of PTSD assessments, we report 
pooled PTSD prevalences across two time frames after critical illness: 1 to 6 months and 7 to 12 months. 
IES-measured PTSD symptom prevalence and mean IES score were pooled using a binomial and linear 
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random-effects model, respectively, with a random intercept for study. The I2 statistic was used to 
evaluate between-study statistical heterogeneity; when the I2 was >50%, indicating substantial 
heterogeneity, a sensitivity analysis was performed in which any study with qualitative evidence of 
heterogeneity was removed and the meta-analysis repeated. We could not assess publication bias due 




Description of Search and Study Characteristics  
The authors identified 4,205 citations and reviewed 2,817 unique titles and abstracts (after de-
duplication of identified citations) and 712 full-text articles, with 40 publications on 36 unique cohorts 
meeting eligibility criteria (Figure 1). The 40 publications included 7 randomized controlled trials 
(RCTs),13,17-22 4 cross-sectional studies,23-26 and 29 prospective cohort studies (Appendix - Table 1),14,18,25-
54 with at least one PTSD assessment completed for 4260 patients, with most assessments occurring 
between 3 and 12 months after critical illness (Appendix - Table 2). The studies were conducted 
predominantly in the United Kingdom13,20,22,24,27,33,34,39,42-44,47,51,53 and United States.21,29,30,41,52,54 
 
Risk of Bias Assessment 
Risk of bias assessment of the included RCTs demonstrated that randomized sequence 
generation and allocation concealment were adequate in most studies (Appendix - Table 3). Double-
blinding was feasible in only one RCT. Assessment of observational studies demonstrated that most 
adequately addressed selection, comparability of groups and outcomes (Appendix - Table 4).  
 
Measures and Prevalence of PTSD 
35 
 
In two studies, PTSD symptoms were assessed using a semi-structured psychiatric interview.25,50 
The remaining publications utilized questionnaires, including most commonly: the IES (16 
publications),17,22-24,32-34,36-39,46,47,49,51,53 the IES-Revised (IES-R) (7 publications),14,18,19,28,35,40,45 and the 
Posttraumatic Symptom Scale-10 (PTSS-10) (6 publications).18,21,25,31,52,54 The assessments were 
conducted in-person, by telephone and by mail in 1513,21,22,32-35,41,42,44,45,47,50,51,53,54, 1513,14,19,26,28-31,33,35,40-
43,45,49, and 11 studies,17,19,20,23,24,27,35-39,46,48 respectively (two studies25,52 did not report how data was 
collected). 
 
In all studies in this review, the point prevalence of PTSD symptoms ranged from 4 to 62% 
(Figure 2).  The IES (potential score range: 0 to 75) was the most commonly used instrument to assess 
PTSD symptoms, with higher scores indicating greater intrusion and avoidance symptoms. Via meta-
analysis of 6 studies (n=456) that utilized the IES at 1-6 months post-ICU, the pooled mean [95% CI] 
score was 20 [17-24; I2=78%], and the pooled prevalence [95% CI] of clinically important PTSD symptoms 
was 25% [18- 34%; I2=68%] and 44% [36-52%; I2=62%] using IES thresholds ≥35 and ≥20, 
respectively.22,33,34,36-38,46,51,53 In 698 patients (5 studies), at 7-12 months post-ICU, the pooled mean IES 
score was 17 [9-24; I2=97%], and pooled prevalences of PTSD symptoms were 17% [10-26%; I2=85%] and 
34% [22-50%; I2=93%].23,34,36-38,46,49,51  
 
In sensitivity analyses, two studies33,53 with qualitative evidence of heterogeneity at 1-6 months 
and one study at 7-1249 months were removed from the meta-analysis, demonstrating similar results. At 
1-6 month follow-up, based on 4 studies (n=385) the pooled mean [95% CI] IES score was 21 [19-22; 
I2=0%], and the pooled prevalences [95% CI] of clinically important PTSD symptoms were 24% [20-29%; 
I2=0%] and 46% [41-52%; I2=14%], using IES thresholds ≥35 and ≥20, respectively.22,33,34,36-38,46,51 At 7-12 
months, the pooled mean IES score for 4 studies (n=529) was 19 [16-22] (I2=75%), and pooled 
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prevalence of PTSD symptoms was 22% [18-27%] (I2=36%) and 43% [35-51%] (I2=63%), 
respectively.15,19,21-23,31,37  
 
Risk Factors for PTSD   
Age was not associated with PTSD symptoms in 9 of 15 studies (Appendix - Table 
5).14,24,26,27,29,30,34,35,38,40,43,45-48,50,54 Sex was not associated with PTSD symptoms in 13 of 17 
studies.13,14,26,27,29,32,34,35,38-41,43,45,46,48,49,54 Pre-ICU psychopathology was associated with PTSD symptoms in 
5 of 9 studies.14,25-27,30,42,43,50,53 The 4 studies that did not report an association between pre-ICU 
psychopathology and PTSD symptoms tended to be smaller (N<60)14,50,53 or assessed only pre-ICU 
depression versus all pre-ICU psychopathology.30  
 
Sedation in the ICU was evaluated for associations with PTSD symptoms. Greater PTSD 
symptoms were associated with receipt of benzodiazepines in 2 of 4 studies14,27,31,40 and higher total 
dose of benzodiazepines in 1 of 2 studies,31,54 but not with duration of benzodiazepines in 1 study.30 
Daily interruption of sedation,21 light versus deep sedation,19 an analgesia-based sedation protocol,31 
and a no-sedation (only bolus doses of morphine) protocol18 were not associated with an increase in 
PTSD symptoms. Duration of delirium or any ICU delirium was not associated with PTSD symptoms in 2 
of 2 studies.30,54  
 
Corticosteroids administered in the ICU had no association with PTSD symptoms in two studies 
with sample sizes of <100.14,29 One of these studies reported greater PTSD symptoms in individuals 
homozygous for the corticotrophin-releasing hormone binding protein (CRHBP) T/T allele, a gene 





Severity of illness and ICU length of stay (LOS) were not significantly associated with PTSD 
symptoms in 11 of 12 studies14,25,29,34,35,40,43,46-48,50,54 and 12 of 14 studies,14,24,27,34,35,37,40,43,45-48,50,54 
respectively.  ICU admission diagnosis was not associated with PTSD symptoms in 7 of 7 
studies.14,27,37,43,45,48,53 nor were mechanical ventilation or mechanical ventilation duration  in 5 of 8 
studies.14,30,37,38,40,43,45,50,54  
 
Early post-ICU memories of frightening ICU experiences (e.g., hallucinations, paranoid delusions, 
and nightmares were associated with PTSD symptoms in 10 of 12 studies.13,17,22,31,34,40-42,45,49,51,53,54  Post-
ICU psychopathology (e.g., anxiety, depression and substance abuse) was associated with PTSD 
symptoms in 4 of 4 studies.40,50,52,53  
  
Interventions to Reduce PTSD Symptoms 
An ICU diary was associated with a significant reduction in PTSD symptoms at 3 to 12 month 
follow-up in 2 studies (RCT, n=352 and prospective study, n=143),13,14 and a self-help rehabilitation 
manual was associated with a significant reduction at 2 months but not at 6 months (RCT, n=126) 
(Appendix - Table 5).22 A nurse-led ICU follow-up clinic showed no benefit for PTSD symptoms in 1 RCT 
(n=286),20 and a pre-post study of a multidisciplinary follow-up clinic (n=258) found benefit for women, 
but not men.32  
 
Association between PTSD and Health-related Quality of Life (HRQOL) 
Six of six studies evaluating the cross-sectional association between PTSD and HRQOL reported 
greater PTSD symptoms were associated with worse mental health-related quality of life (Appendix - 
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This systematic review and meta-analysis of PTSD symptoms in critical illness survivors 
demonstrates clinically important PTSD symptoms occur in 1/5 of patients in the first 12 months post-
ICU and are associated with worse HRQOL. Variables associated with PTSD symptoms in ICU survivors 
include: benzodiazepines in the ICU, early memories of frightening ICU experiences and pre-ICU 
comorbid psychopathology. Severity of illness, admission diagnosis and ICU LOS are consistently not 
associated with PTSD symptoms. ICU diaries are associated with a reduction in PTSD symptoms.  
 
The pooled prevalence of clinically important PTSD symptoms (IES score ≥ 35) 1-6 and 7-12 
months after ICU discharge was 24% and 22%, respectively. In a sensitivity analysis, two studies in the 1-
6 and one study in the 7-12 month intervals were identified for removal from the meta-analysis due to 
heterogeneity. Unlike the other studies in the meta-analysis, one study33 removed at 1-6 months 
assessed PTSD symptoms using multiple instruments at the same time point in the setting of a relatively 
small sample size, and another study53 assessed PTSD symptoms relatively early (2 months post-
discharge). The study removed at 7-12 months49 had two important distinctions that might account for 
its low prevalence estimates: 1) the IES was translated into Spanish and 2) there was a low proportion 
(15%) of patients with a primary diagnosis of respiratory failure.  Statistical measures of heterogeneity 
improved after the sensitivity analysis with modest changes in the pooled results.  
 
Compared with the 22% pooled prevalence of PTSD symptoms in critical illness survivors, the 
prevalence of PTSD symptoms following acute coronary syndromes was 12% in one recent meta-analysis 
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including studies utilizing similar PTSD instruments as in this review.55 In a prospective cohort study of 
major traumatic injury patients, 23% had an IES score ≥35 at 1 year follow-up.56 Although different 
instruments with possibly stricter thresholds were used, the prevalence of clinically important PTSD 
symptoms in critical illness survivors in this meta-analysis was generally comparable to survivors war-
time combat57,58 (11-31% ),  and the World Trade Center attacks59,60 (11-23%).   
 
Establishing standardized assessments to measure PTSD symptoms in critical illness survivors is 
important, as highlighted by a comparison between the pooled prevalence of PTSD symptoms at 1 year 
post-ICU from this meta-analysis and the 7% estimate provided in a recent large (N~400) prospective 
study published after the systematic review.61 Notably, the instrument used in the prospective cohort, 
the PTSD Checklist, was used by only two studies in the systematic review that also reported a lower 
prevalence of PTSD symptoms than the pooled prevalence from the meta-analysis.19,29,30 Only two 
instruments have been validated against clinician diagnostic semi-structured interviews in survivors of 
critical illness: the PTSS-10 (sensitivity 77% and specificity 97%)62 and IES-R (area under the receiving 
operating characteristics curve (AUC) 95% [88 – 100%]).63,64 A study in this review validated the PTSS-14 
against the Posttraumatic Stress Diagnostic Scale (AUC 82-95%).33 The 36 unique cohorts in this 
systematic review used eight different questionnaires with substantial variability in scoring, follow-up 
periods, and risk factors assessed, making comparisons across studies difficult. The field could be 
advanced by use of common survey instruments validated against “gold standard” diagnostic 
instruments, with standardized follow-up time point(s), scoring methods and thresholds, and reporting 
of both continuous and binary (i.e. above threshold) PTSD symptom data.1,2,65 
 
Pre-existing psychopathology was the only pre-ICU factor consistently associated with PTSD 
symptoms. Importantly, and also in line with prior reviews, the following ICU-related factors were 
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consistently not associated with PTSD symptoms: severity of illness, admission diagnosis, ICU LOS and 
mechanical ventilation. 
 
In this systematic review, two ICU-related variables had important associations with PTSD: 
sedation and early memories of frightening ICU experiences. It is unclear if associations between 
benzodiazepine sedation and PTSD symptoms reflect a true causal relationship or whether patients with 
high in-ICU anxiety (a possible independent risk factor for PTSD symptoms) simply receive higher doses 
of sedatives. Sedation may contribute to PTSD symptoms through delirium; however, of the two studies 
in this systematic review that evaluated the association between in-ICU delirium and later PTSD 
symptoms, neither found a significant association.30,54 Similarly, a longitudinal study of PTSD symptoms 
in ARDS survivors, excluded because it focused on a sub-population of ICU survivors, did not 
demonstrate a relationship between duration of delirium and later PTSD symptoms.66 The authors 
hypothesized that the study lacked statistical power to detect a difference in PTSD symptoms with 
presence/absence of delirium because virtually all of the patients experienced in-ICU delirium.66 Perhaps 
sedation contributes to PTSD symptoms not through the duration of delirium but through an increased 
recall of in-ICU nightmares/psychotic experiences that may have been enhanced by delirium.7,42  
 
There are already several known benefits of interruption of sedation paired with spontaneous 
breathing trials.67-70 In this systematic review, interruption of sedation, light versus deep sedation, and 
analgesia-based sedation did not increase, and in fact, showed trends towards decreased PTSD 
symptoms. In a longitudinal study of ARDS survivors, high dose opiates were associated greater PTSD 
symptoms while the duration of exposure to opiates was associated with less PTSD symptoms, 
suggesting that sufficient pain control may be protective while excessive opiate dosing may contribute 
to sedation and subsequent PTSD symptoms.66  
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Several reports involving PTSD symptoms in patients surviving specific illness (e.g. cardiac surgery, 
sepsis, ARDS) as well as wartime combat have demonstrated that corticosteroids may protect against 
PTSD symptoms, perhaps by their role in consolidation of traumatic memories.66,71-74 While two 
studies29,75 in this review did not find a significant association between corticosteroids in the ICU and 
PTSD symptoms, one of these studies highlighted that individuals who were homozygous for the CRHBP 
T/T allele, a gene involved in the HPA axis, had greater PTSD symptoms.29 Another study, not included in 
this review because it focused exclusively on cardiac surgery patients, found individuals homozygous for 
the BCl1 G allele, also involved in the HPA axis, had greater PTSD symptoms.76  
 
Since the publication of prior systematic reviews,6,7,9 there has been increasing focus on 
interventions to reduce clinically important PTSD symptoms. Two studies in this systematic review 
reported patients receiving an ICU diary had fewer PTSD symptoms; this intervention has become 
standard care in some European ICUs (International ICU Diary Network www.icu-diary.org). Another 
study taking place in a trauma ICU, and therefore not included in this systematic review of general 
critical illness survivors, found an “early intra-ICU psychological intervention” was associated with less 
PTSD symptoms.77 A third promising intervention, a post-ICU discharge telephone-based coping skills 
intervention, has also shown benefits in reducing PTSD symptoms in a very small (n=7) pilot study.78 
Prolonged exposure therapy, the mainstay of treatment for PTSD in other populations,79,80 has not been 
assessed in this population, and its feasibility and benefit remains uncertain. 
 
This systematic review has several important limitations. First, with the exception of one study, 
PTSD symptoms were assessed using questionnaires. Ideally, studies would utilize a clinician diagnostic 
semi-structured interview, but this is not feasible in large multi-center studies. The heterogeneity of 
42 
 
sample populations and PTSD symptom instruments makes direct comparison difficult. However, the 
use of meta-analysis to pool the results of the 11 studies using the IES for PTSD symptom assessment 
strengthens the assertion that PTSD symptoms are highly prevalent among general critical illness 
survivors. Additionally, our exclusion of studies focusing on patient populations with a specific illness 
may affect generalizability of our results.  However, some specific ICU survivor populations (e.g., trauma 
or cardiac surgery patients) may, in fact, be distinct from other survivors in terms of their prevalence of 
PTSD symptoms and possible risk factors. Finally, although care was taken to identify all potentially 
relevant studies for this systematic review, it is possible that some studies were inadvertently omitted.  
 
In conclusion, PTSD symptoms occurred in 1/5 of critical illness survivors over 1-year follow-up, 
with higher prevalences in those who had comorbid psychopathology, received benzodiazepines, and 
had early post-ICU memories of frightening ICU experiences. Given the association between PTSD 
symptoms and worse HRQOL, identification of risk factors is important to target patients for 
prevention/treatment interventions and motivate changes in ICU practices that are associated with 
subsequent PTSD symptoms. One such intervention, ICU diaries, reduced PTSD symptoms in European 
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Objective: To evaluate prevalence, severity, and co-occurrence of, and risk factors for depression, 
anxiety, and post-traumatic stress disorder (PTSD) symptoms over the first year after ARDS. 
Design: Prospective longitudinal cohort study. 
Settings: 41 ARDS Network hospitals across the U.S. 
Patients: 698 ARDS survivors. 
Interventions: None. 
Measurements and Main Results: Psychiatric symptoms were evaluated using the Hospital Anxiety and 
Depression Scale (HADS) and Impact of Event Scale–Revised (IES-R) at 6 and 12 months. Adjusted 
prevalence ratios for substantial symptoms (binary outcome) and severity scores were calculated using 
Poisson and linear regression, respectively. During 12 months, a total of 416 of 629 patients (66%) with 
at least one psychiatric outcome measure had substantial symptoms in at least one domain. There was a 
high and almost identical prevalence of substantial symptoms (36%, 42%, and 24% for depression, 
anxiety and PTSD) at 6 and 12 months. The most common pattern of co-occurrence was having 
symptoms of all 3 psychiatric domains simultaneously. Younger age, female sex, unemployment, alcohol 
misuse, and greater opioids use in the ICU were significantly associated with psychiatric symptoms, 
while greater severity of illness and ICU length of stay were not associated. 
Conclusions: Psychiatric symptoms occurred in two-thirds of ARDS survivors with frequent co-
occurrence. Sociodemographic characteristics and in-ICU opioids administration, rather than traditional 
measures of critical illness severity, should be considered in identifying patients at highest risk for 
psychiatric symptoms during recovery. Given high co-occurrence, ARDS survivors should be 





Survivors of acute respiratory distress syndrome (ARDS) frequently experience substantial long-term 
psychiatric symptoms after hospital discharge.(1-10)  Pro-inflammatory cytokines, frightening memories 
experienced in the intensive care unit (ICU), and stressful life changes after hospital discharge may be 
potential causes for psychiatric symptoms.(6) In ARDS survivors, systematic reviews have reported point 
prevalences of 17% to 43% for depression, 23% to 48% for anxiety, and 8% to 35% for post-traumatic 
stress disorder (PTSD) symptoms,(6;7;9) with common risk factors including younger age, female sex, 
obesity, pre-existing psychiatric illness, lower educational attainment, baseline unemployment, and 
lower blood glucose in the ICU.(1;3;4;7;9)  
However, most existing publications are single-center studies with modest sample sizes that evaluate a 
single psychiatric domain in isolation. Few studies have evaluated multiple psychiatric outcomes in 
multiple institutions with large sample sizes.(6;11) These limitations contribute, in part, to conflicting 
results in evaluating risk factors for psychiatric symptoms after ARDS.  To better inform clinicians’ and 
researchers’ efforts to effectively identify and treat these important morbidities, additional research is 
required regarding the prevalence, severity, co-occurrence and risk factors for psychiatric symptoms, 
using larger-sized, multi-centered, longitudinal studies to simultaneously evaluate commonly reported 
symptoms.  
Hence, our study longitudinally evaluates, over the first year after ARDS, the prevalence, severity and co-
occurrence of depression, anxiety, and PTSD symptoms, as well as patient- and critical illness-related risk 






Participants were part of the ARDS Network (ARDSNet) Long-term Outcome Study (ALTOS), a national, 
multi-center, prospective cohort study evaluating outcomes at 6 and 12 months after enrollment into 
three recent ARDSNet clinical trials evaluating ICU-based therapies for ARDS patients. The eligibility 
criteria for these three ARDSNet trials have been published previously and are summarized 
herein.(12;13) Patients were eligible for recruitment within 48 hours of ARDS onset and within 72 hours 
of initiation of mechanical ventilation.  Major exclusion criteria included severe comorbid malnutrition; 
lung, liver or neuromuscular diseases; or limitations in life support at time of eligibility.(12;13) For 
follow-up evaluations in ALTOS, we further excluded survivors from the ARDSNet trials if they had 
potential cognitive impairment prior to admission (ascertained via medical records and/or patient/proxy 
report), or were non-English speaking, homeless, or younger than 18 years old.  Across all participating 
sites, patients were managed with simplified versions of lung protective mechanical ventilation and fluid 
conservative hemodynamic management protocols, with blood glucose control aimed at 80-150 mg/dL 
(tighter glucose control was permitted).  Informed consent was obtained from the patient or a proxy. 
This study was approved by the Institutional Review Board at Johns Hopkins University and all 
participating hospitals. 
Measurement of Patient- and Critical Illness-Related Exposures 
Both patient- and critical illness-related exposures were obtained from ALTOS and the ARDSNet trials.  
Patient-related baseline exposures included demographics, employment status (unemployed vs. 
employed), body mass index (BMI), medical comorbidities (diabetes mellitus, prior stroke, and use of 
hemodialysis), and alcohol misuse. Alcohol misuse was defined by zones 3 and 4 from the Alcohol Use 
Disorders Identification Test (AUDIT) risk levels, which indicate alcohol consumption in excess of 
recommended limits. (14) Critical illness-related baseline exposures included admission to a medical 
(versus surgical) ICU, severity of illness (i.e., Acute Physiology and Chronic Health Evaluation (APACHE) III 
score, and partial pressure of oxygen in arterial blood to fraction of inspired oxygen (PaO2/FiO2) ratio), 
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and ARDS risk factor (sepsis versus all others). While in the ICU, the following were collected daily for up 
to 12 days after enrollment:  (1) the Brussels organ failure status for the cardiovascular, pulmonary, 
coagulation, renal and hepatic systems(15) (modeled as the mean number of organ failures during data 
collection), (2) use of hemodialysis and vasopressors (modeled as binary variables), (3) use of opioids, 
corticosteroids, and neuromuscular blockers (modeled as the percentage of ICU days with use), and (4) 
morning and daily minimum blood glucose (modeled as mean values). Mechanical ventilation duration 
and ICU length of stay data were also collected.  
 Measurement of Psychiatric Symptoms  
The outcome variables of interest were symptoms of depression, anxiety, and PTSD at 6 and 12 months 
after ARDS. Anxiety and depression symptoms were measured using the respective subscales of the 
Hospital Anxiety and Depression Scale (HADS) instrument.(16) Each HADS subscale ranges from 0 to 21, 
with a higher score indicating worse symptoms and a score >8 indicating substantial symptoms.(16) 
PTSD symptoms were measured using the Impact of Event Scale-Revised (IES-R).  The IES-R score ranges 
from 0 to 4, with a higher score indicating worse PTSD symptoms(17) and a score >1.6 indicating 
substantial PTSD symptoms in ARDS survivors.(18) Both scales were administered to patients only (i.e. 
no proxy respondents) by trained research staff via phone for 98% of assessments, otherwise via mail or 
in-person administration. These scales have evidence of good reliability and validity, and have been 
frequently used in prior studies evaluating survivors of critical illness.(1;9;18;19)  
Statistical Analysis 
We compared all exposure variables (see Table 1) by binary categorization of the three psychiatric 
domains at 6 months using Fisher’s exact tests and t-tests. For both the 6- and 12-month time points, 
correlations of continuous psychiatric symptom scores were calculated using the Spearman correlation 
coefficient, and co-occurrence of substantial psychiatric symptoms was evaluated by calculating the 
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proportion of patients who had substantial symptoms in more than one domain. The prevalence and co-
occurrence were illustrated via a proportioned Venn diagram utilizing the “pvenn” command (Stata 
version 13.0, StataCorp, College Station, TX). 
Associations between each exposure variable and substantial symptoms for each of the three psychiatric 
domains (binary outcome variables, as previously defined) were evaluated using Poisson regression. We 
evaluated these associations separately at 6- and 12-month follow-up; however, due to statistically 
similar associations at both time points, we adopted a simplified approach combining 6- and 12-month 
follow-up visits. For this combined approach, the models included an indicator for time (12- vs. 6-month) 
and were fitted using generalized estimating equations (GEE), with an exchangeable correlation 
structure and robust variance estimate to account for within-patient clustering over 6- and 12-month 
follow-ups. For continuous measures of symptom severity for each of the three psychiatric domains, a 
similar statistical approach was employed using linear regression models. Multivariable regression 
models were constructed in the same manner as the bivariable models and included all exposure 
variables that had a potentially significant bivariable association of p<0.20 with each psychiatric domain. 
Regardless of bivariable association, ICU length of stay was included in the multivariable models to 
standardize evaluation of daily ICU exposure variables, and baseline use of hemodialysis was included to 
adjust for pre-existing renal disease when including hemodialysis in the ICU in the multivariable models. 
To evaluate the effect of potential confounding by pre-existing psychiatric comorbidity on the results, 
we conducted sensitivity analysis using a subgroup of patients (n=203) from 5 of the 12 study sites on 
whom we prospectively collected baseline psychiatric comorbidity based on medical records.  In this 
analysis, we evaluated the exposure-outcome assessments with vs. without this comorbidity in the 
original multivariable model. 
Standard regression diagnostics were conducted for all models. The linearity assumption was verified by 
assessing locally weighted scatterplot smoothing of each exposure variable against residuals from the 
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regression model. Only age demonstrated a non-linear relationship with outcomes, so we categorized 
age into four quartiles (18-39, 40-49, 50-59, and 60-89 years), with the last quartile (60-89) as the 
reference. We confirmed that there was no multi-collinearity by evaluating variance inflation 
factors.(20) Since missing data were rare (<5% of all survivors at each of 6 and 12 months), regression 
analysis was done using the available data without imputation. P-values were two-sided, and statistical 
significance was defined as p<0.05. All statistical analyses were performed using Stata 13.0 (StataCorp, 
College Station, TX). 
RESULTS 
Among 1,176 patients enrolled in the three ARDSNet trials, 247 (21%) died by hospital discharge, an 
additional 44 (5% of hospital survivors) died before re-consent, and 187 (20% of hospital survivors) met 
ALTOS exclusion criteria, leaving a total of 698 (59%) who survived hospital stay and were eligible and 
consented for follow-up (Figure 1). A total of 645 (98%) of 656 and 606 (95%) of 635 survivors had 
follow-up visits at 6 and 12 months, respectively.  Among them, 613 (95%) and 576 (95%) completed at 
least one psychiatric instrument at 6- and 12-month follow-up, respectively, with 629 patients 
completing at least one psychiatric instrument over one-year longitudinal follow-up. 
Participating patients had a mean age of 49 years, with 52% female, 82% white and 49% unemployed 
prior to hospital admission (Table 1). Patients with substantial psychiatric symptoms during follow-up 
were more likely (p<0.05 based on Fisher’s exact and t-tests) to be younger, female, unemployed prior 
to ARDS, have alcohol misuse history, be less acutely ill (i.e. lower APACHE III score at ICU admission), 
and receive opioids for a greater proportion of ICU stay (Table 1). 
Individual Psychiatric Domains and their Co-occurrence  
Among 629 patients with at least one psychiatric measure, 416 (66%) had substantial symptoms in >1 
domain during one-year follow-up.  At 6 months (Table 1), the prevalence of substantial symptoms of 
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depression, anxiety, and PTSD was 36% (222/613), 42% (260/613), and 24% (148/605), respectively, with 
almost identical prevalence at 12 months (36% (204/574), 42% (241/575), and 23% (132/573)).  Across 
all three domains, the multivariable models demonstrated no significant change in prevalence or 
severity of psychiatric morbidity over time (Tables 2 and 3). Of patients who had substantial symptoms 
of depression, anxiety, and PTSD at 6 months, 57%-66% still had the same symptoms at 12 months, and 
<15% of patients without substantial symptoms at 6 months developed symptoms later. 
Continuous scores for psychiatric symptoms during follow-up were correlated as follows: depression and 
anxiety (Spearman’s rho: 0.70-0.72, p<0.001), anxiety and PTSD (0.69 at both time points, p<0.001), and 
depression and PTSD (0.58-0.59, p<0.001). The majority of survivors (63%) with any psychiatric 
morbidity (i.e. depression, anxiety, and/or PTSD symptoms) had substantial symptoms in two or more 
domains. At 6 months, 325 (53%) of 613 patients had substantial symptoms in at least 1 of the 3 
domains assessed in this study.  Among these symptomatic patients, the most common pattern of co-
occurrence of symptoms involved simultaneously having substantial symptoms of depression, anxiety, 
and PTSD (n=106, 33%), followed by substantial depression and anxiety symptoms (18%), substantial 
anxiety and PTSD symptoms (7%), and substantial depression and PTSD symptoms (3%) (Figure 2).  
Similar results were observed at 12 months.  
Risk Factors for Substantial Psychiatric Symptoms and Severity 
The bivariable and multivariable prevalence ratios for each psychiatric domain by risk factors are 
reported in Table 2. Female sex, unemployment prior to hospital admission, and alcohol misuse were 
associated with substantial symptoms in all three psychiatric domains.   Younger age was significantly 
associated with substantial anxiety and PTSD symptoms, and a greater proportion of ICU days with 
opioids administration was significantly associated with substantial anxiety and depression symptoms 
(Table 2). Risk factor associations were similar when psychiatric symptoms were modeled as continuous 
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variables (Table 3). Specifically, female sex, unemployment, and a greater in-ICU opioid use were 
associated with symptoms in all three domains. Younger age, alcohol misuse, and greater in-ICU 
neuromuscular blocker use were associated with more severe anxiety and PTSD symptoms.  
Sensitivity analysis demonstrated that pre-existing psychiatric comorbidity was associated with each 
psychiatric domain in continuous analyses and only with anxiety in binary analyses. Adding psychiatric 
comorbidity in both continuous and binary multivariable models demonstrated relatively little change in 
the overall results with the risk factors for depression remaining significant, unemployment no longer 
being significant for anxiety, and female sex no longer being significant for PTSD. 
In both binary and continuous analyses, greater severity of illness (i.e., APACHE III, PaO2/FiO2 ratio, 
number of organ failures, hemodialysis, and vasopressors), consistently was not associated with, or was 
negatively associated with, psychiatric symptoms. Moreover, there was no association between type of 
ICU, ARDS risk factor (sepsis vs. others), mechanical ventilation duration, and ICU length of stay with 
psychiatric symptoms in any analysis (Tables 2 and 3). 
DISCUSSION 
In this national, multicenter, longitudinal follow-up study evaluating psychiatric symptoms in over 600 
ARDS survivors, two-thirds of participants had substantial symptoms in at least one psychiatric domain 
during 12-month follow-up.  There was high prevalence, persistence, and co-occurrence of depression, 
anxiety, and PTSD symptoms.  Severity of illness, mechanical ventilation duration and ICU length of stay 
were not associated with worse psychiatric symptoms.  Younger age, female sex, baseline 
unemployment, alcohol misuse, and greater in-ICU use of opioids were consistently significant markers 
for post-ICU psychiatric symptoms.  
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At 6 months, the prevalence of substantial symptoms of depression, anxiety, and PTSD were high at 
36%, 42%, and 24%, without improvement at 12 months. These prevalence rates are much higher than 
those in the general population,(21;22) but comparable with prior smaller, single-centered studies of 
ICU survivors.(4-7) Moreover, our findings of the persistence, frequent co-occurrence, and moderate to 
high correlation of psychiatric symptoms are also built upon prior studies of ICU survivors.(2;5;8;23-26)  
Notably, anxiety and depression symptoms observed in this study may reflect pre-ARDS psychiatric 
morbidity; however, when accounting for pre-ICU psychiatric status, critical illness may remain an 
independent risk factor for new post-ICU psychiatric morbidity.(27;28) Moreover, PTSD symptoms, 
reported in approximately one-quarter of survivors in this study, likely represent incident psychiatric 
symptoms post-ARDS, since the IES-R instrument used in this study specifically addresses patients’ 
symptoms in relation to their critical illness and ICU experience. 
Our findings add to the growing body of evidence that psychiatric symptoms are a significant and 
prolonged burden for ICU survivors, and that patient and critical illness factors may be markers for these 
symptoms. The positive associations of younger age, female sex and unemployment with psychiatric 
symptoms are recognized in ICU survivors and other patient populations.(1;4;29-35) Notably, however, 
our sensitivity analysis suggests that the association of unemployment with anxiety and female sex with 
PTSD may be a marker for patients who have pre-existing psychiatric comorbidity rather than 
independent risk factors. While existing findings have been inconsistent about alcohol use disorder as a 
predictor for developing psychiatric conditions, our study suggests that it is strongly associated with 
psychiatric symptoms and severe outcomes.(36-40) 
A longer duration of opioid exposure was the only ICU-related risk factor consistently and positively 
associated with symptoms in all three psychiatric domains. A prior study of ARDS survivors 
demonstrated that a high mean daily dose of opioids (≥100mg of morphine equivalents per day) was 
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positively associated with PTSD symptoms measured by IES-R, but a greater proportion of ICU days with 
opioid was negatively associated with PTSD symptoms.(9) It has been speculated that adequate pain 
control using opioids may have a preventive effect on PTSD.(9;41-43) Unfortunately, data on opioid 
dosing was not available to further evaluate this issue in our study.  Future research in survivors of 
critical illness should investigate, in greater detail, the potentially complex role of in-ICU opioid 
administration and dosage.   
Of note, our study demonstrated that five different measures of severity of illness, along with 
mechanical ventilation duration and ICU length of stay, had no positive association with psychiatric 
symptoms. Notably, a higher APACHE III score was associated with lower symptom scores, which might 
reflect that patients with higher severity of illness who survived their ICU stay had less pre-existing 
psychiatric illness or had another unmeasured factor that was protective against post-ICU psychiatric 
symptoms. Despite these findings contradicting positive associations of illness severity with post-ARDS 
physical impairments and mortality,(11;44-48) our findings agree with prior studies evaluating 
psychiatric symptoms in both ARDS and other ICU survivors.(30-32;49;50) Hence, it is critical for 
clinicians to recognize that patients with anticipated better physical outcomes, due to a lower severity 
of illness and shorter length of stay, should not be overlooked when considering risk for post-ICU 
psychiatric symptoms.(9;49;50) 
The strengths of this study include being a national, longitudinal, prospective study with large sample 
size, high retention rate (>95%), and simultaneous evaluation of prevalence, severity, co-occurrence and 
risk factors for three common psychiatric morbidities.  However, the study has potential limitations.  
First, our study focused on relatively young ARDSNet trial survivors with exclusions for severe comorbid 
diseases.  Hence, the findings may not be generalizable to other populations. However, comparisons of 
our findings to the existing literature generally revealed consistency of results, which may support 
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generalizability. Second, this evaluation was restricted to the variables collected as part of the ARDSNet 
trials, omitting potentially relevant variables, such as baseline neuropsychological and physical 
functioning status, ICU exposure to sedatives, dose-related data for the opioid and corticosteroid, and 
daily pain, sedation and delirium assessments.  Inclusion of such variables in future large-scale studies is 
highly recommended. Third, given its observational design, our study cannot demonstrate cause-effect 
relationships; hence, the results should be recognized as markers of risk for post-ARDS psychiatric 
symptoms, rather than as direct causal associations. We could be underpowered to identify a true 
association between severity of illness and psychiatric symptoms, but prior literature supports our 
findings. Finally, we used self-reported measures of psychiatric symptoms without ascertaining clinical 
psychiatric diagnoses and could only determine the prevalence, rather than incidence of depression and 
anxiety symptoms. However, the HADS and IES-R are commonly used and well-validated 
instruments.(1;9;18;19)  Moreover, they have the advantages of providing both a binary result and a 
continuous measure of symptom severity, and being feasible to administer to a large geographically 
dispersed national patient cohort.(9) In addition, the IES-R instrument used in this study evaluates PTSD 
symptoms with respect to patients’ critical illness, thus likely evaluating incident symptoms. The IES-R 
instrument has high discrimination (area under the receiver operating characteristics = 95%) in 
screening for a clinical diagnosis of PTSD in ARDS survivors.(18) 
CONCLUSION 
Two-thirds of ARDS survivors had substantial symptoms of depression, anxiety or PTSD during 12-month 
follow-up. We observed high co-occurrence among these psychiatric domains, particularly co-
occurrence of all three morbidities. Younger age, female sex, unemployment prior to hospital admission, 
alcohol misuse, and greater in-ICU use of opioids were significant markers for these symptoms. 
However, traditional risk factors for post-ICU physical impairment were not associated with worse 
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symptoms.  These findings have value in identifying patients at greatest risk of psychiatric symptoms 
during recovery from critical illness, and emphasize the need to simultaneously evaluate for a full 
spectrum of potential sequelae to maximize patient recovery.   
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Table 1. Baseline characteristics for all patients and by psychiatric symptoms at 6 months after acute respiratory distress syndrome 



























Baseline patient data        
Age, mean (SD) year 49 (15) 48 (12) 49 (16) 48 (12) 50 (16) 47 (12) 50 (15) 
Female, N (%) 316 (52) 127 (57) 189 (48) 155 (60) 161 (46) 100 (68) 213 (47) 
White, N (%) 485 (82) 174 (81) 311 (82) 211 (84) 274 (80) 108 (78) 371 (83) 
Unemployed, N (%) 296 (49) 130 (59) 166 (43) 143 (56) 153 (44) 88 (60) 205 (45) 
BMI, mean (SD) kg/m2 30 (8) 31 (8) 30 (8) 31 (8) 30 (8) 31 (8) 30 (8) 
Diabetes, N (%) 146 (24) 52 (23) 94 (24) 62 (24) 84 (24) 32 (22) 110 (24) 
Stroke, N (%) 9 (2) 5 (2) 4 (1) 4 (2) 5 (1) 4 (3) 4 (1) 
Hemodialysis, N (%) 14 (2) 9 (4) 5 (1) 7 (3) 7 (2) 6 (4) 8 (2) 
Alcohol misuse, N (%) 126 (22) 52 (25) 74 (20) 60 (24) 66 (20) 36 (26) 88 (21) 
Baseline intensive care data        
Admission to medical ICU, N (%) 350 (57) 124 (56) 226 (58) 151 (58) 199 (56) 86 (58) 259 (57) 
APACHE III, mean (SD) 86 (26) 82 (25) 88 (26) 83 (26) 88 (25) 83 (26) 87 (25) 
PaO2/FiO2, mean (SD) 204 (73) 209 (76) 200 (72) 202 (65) 205 (79) 207 (71) 202 (74) 
Sepsis as ARDS risk factor, N (%) 467 (76) 157 (71) 310 (79) 195 (75) 272 (77) 108 (73) 352 (77) 
Daily intensive care data        
No. of organ failuresc, mean (SD) 2 (1) 2 (1) 2 (1) 2 (1) 2 (1) 2 (1) 2 (1) 
Any hemodialysis, N (%) 76 (14) 22 (11) 54 (15) 24 (10) 52 (17) 19 (14) 56 (14) 
Any vasopressor use, N (%) 325 (53) 110 (50) 215 (55) 137 (53) 188 (53) 81 (55) 240 (53) 
% of days with opioids, mean (SD) 73 (30) 78 (28) 70 (31) 76 (28) 70 (32) 79 (27) 71 (31) 
% of days with corticosteroids, mean 
(SD) 
21 (35) 23 (37) 20 (34) 21 (36) 20 (34) 24 (37) 20 (34) 
% of days with neuromuscular 















Morning glucose, mean (SD) mg/dl, 127 (26) 127 (26) 127 (26) 126 (26) 128 (26) 126 (26) 128 (26) 
Minimum glucose, mean (SD) mg/dl 110 (23) 110 (25) 111 (21) 108 (23) 112 (22) 108 (20) 111 (23) 
Other intensive care data        
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Ventilation duration, mean (SD) day 11 (10) 11 (10) 11 (10) 10 (8) 11 (11) 11 (9) 11 (10) 
ICU length of stay, mean (SD) day d 14 (11) 14 (11) 14 (11) 13 (10) 15 (12) 14 (10) 14 (11) 
 
Abbreviations: ARDS (acute respiratory distress syndrome), PTSD (post-traumatic stress disorder), HADS (Hospital Anxiety and Depression Scale), 
IES-R (Impact of Event Scale – Revised), SD (standard deviation), BMI (body mass index), ICU (intensive care unit), APACHE III (Acute Physiology 
and Chronic Health Evaluation III), PaO2/FiO2 (ratio between partial pressure of oxygen in arterial blood and fraction of inspired oxygen). 
 
a Percentages may not add up to 100% due to rounding.  Missing data for each variable (N): white (19), unemployed (10), BMI (2), alcohol misuse 
(42), APACHE III score (17), PaO2/FiO2 ratio (19), any hemodialysis (58), % of days with opioids (130), % of days with corticosteroids (120), % of 
days with neuromuscular blocker (130), morning glucose (1), and minimum glucose (101). 
b Missing PTSD assessments for 8 (1%) of 613 patients. 
c Data represent the average number of organ failures during ICU stay, using the Brussels scoring system(20) for the following five organ systems 
(with definition of organ failure):  cardiac (systolic blood pressure <90 mmHg or use of vasopressor), pulmonary (PaO2/FiO2 ratio <300), 
coagulation (platelets <80 x 109/L), renal (creatinine >2.0 mg/dL ) and hepatic (bilirubin >2.0 mg/dL). 
 













Table 2. Variables associated with presence versus absence of substantial psychiatric symptoms  
 Prevalence ratio (95% CI) of substantial psychiatric symptomsa,b,c 
 Depression Anxiety PTSD 
Variables  Bivariable Multivariable Bivariable Multivariable Bivariable Multivariable 
Baseline patient data       
Age quartile (younger vs. older)d 1.03 (0.95, 1.12)  1.13 (1.05, 1.21) 1.16 (1.07, 1.26)  1.22 (1.10, 1.36) 1.23 (1.08, 1.41) 
Female 1.24 (1.02, 1.50) 1.26 (1.01, 1.58) 1.41 (1.19, 1.66) 1.43 (1.18, 1.74) 1.78 (1.37, 2.32) 1.80 (1.31, 2.48) 
White  0.99 (0.78, 1.26)  1.12 (0.89, 1.40)  0.83 (0.62, 1.13)  
Unemployed  1.50 (1.24, 1.83) 1.35 (1.09, 1.69) 1.31 (1.11, 1.55) 1.26 (1.05, 1.52) 1.51 (1.17, 1.95) 1.40 (1.03, 1.90) 
BMI, per 10 kg/m2 1.07 (0.96, 1.20)  1.11 (1.01, 1.22) 1.14 (1.03, 1.26) 1.07 (0.93, 1.24)  
Diabetes 1.06 (0.86, 1.30)  0.99 (0.82, 1.20)  0.85 (0.63, 1.14)  
Stroke 1.39 (0.74, 2.58)  1.04 (0.49, 2.18)  1.61 (0.76, 3.43)  
Hemodialysis 1.29 (0.82, 2.03) 1.54 (0.86, 2.75) 1.05 (0.63, 1.77) 1.26 (0.75, 2.12) 1.39 (0.72, 2.67)  
Alcohol misuse 1.22 (0.99, 1.50) 1.39 (1.09, 1.77) 1.19 (0.99, 1.44) 1.45 (1.18, 1.79) 1.35 (1.02, 1.79) 1.79 (1.31, 2.46) 
Baseline intensive care data       
Admission to medical ICU 0.99 (0.82, 1.20)  1.02 (0.87, 1.21)  1.00 (0.77, 1.28)  
APACHE III, per 20 unit 0.90 (0.83, 0.97) 0.90 (0.82, 0.99) 0.89 (0.84, 0.96) 0.95 (0.88, 1.02) 0.89 (0.80, 0.98) 0.88 (0.79, 0.98) 
PaO2/FiO2, per 20 unit 1.01 (0.98, 1.04)  0.99 (0.97, 1.01)  1.01 (0.98, 1.04)  
Sepsis as ARDS risk factor 0.88 (0.71, 1.08)  0.99 (0.82, 1.20)  0.91 (0.68, 1.21)  
Daily intensive care data       
No. of organ failures 0.90 (0.78, 1.05) 0.94 (0.76, 1.18) 0.84 (0.73, 0.96) 0.88 (0.73, 1.07) 0.99 (0.81, 1.21)  
Any hemodialysis 0.66 (0.47, 0.92) 0.69 (0.45, 1.04) 0.67 (0.48, 0.91) 0.77 (0.53, 1.12) 0.95 (0.64, 1.43)  
Any vasopressor use 0.94 (0.78, 1.14)  0.98 (0.83, 1.16)  1.12 (0.87, 1.44)  
% of days with opioids, per 20%  1.10 (1.02, 1.19) 1.11 (1.03, 1.20) 1.07 (1.01, 1.14) 1.08 (1.01, 1.15) 1.13 (1.02, 1.25) 1.09 (0.98, 1.22) 
% of days with corticosteroids, 
per 20%  
1.02 (0.96, 1.08)  1.02 (0.97, 1.07)  1.05 (0.98, 1.13) 1.04 (0.96, 1.12) 
% of days with neuromuscular 
blocker, per 20%  
1.00 (0.87, 1.17)  1.12 (1.02, 1.24) 1.12 (0.99, 1.27) 1.14 (0.96, 1.35) 1.23 (1.02, 1.49) 
Morning glucose, per 20 mg/dL  1.01 (0.94, 1.09)  0.98 (0.92, 1.05)  0.96 (0.87, 1.06)  
Minimum glucose, per 20 
mg/dL  
1.00 (0.91, 1.10)  0.96 (0.87, 1.05)  0.94 (0.84, 1.06)  
Other intensive care data       
Mechanical ventilation 
duration, per week 
1.02 (0.95, 1.08)  0.99 (0.93, 1.05)  1.02 (0.94, 1.11)  
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ICU length of stay , per week 1.01 (0.95, 1.07) 1.00 (0.93, 1.08) 0.98 (0.93, 1.03) 0.95 (0.88, 1.02) 1.00 (0.92, 1.08) 0.93 (0.83, 1.04) 
Change at 12 vs. 6 month 
follow-upe 
 1.00 (0.89, 1.13)  0.91 (0.83, 1.01)  0.90 (0.77, 1.06) 
 
Abbreviations: CI (confidence interval), PTSD (post-traumatic stress disorder), BMI (body mass index), ICU (Intensive Care Unit), APACHE III 
(Acute Physiology and Chronic Health Evaluation III), PaO2/FiO2 (ratio between partial pressure of oxygen in arterial blood and fraction of 
inspired oxygen), ARDS (acute respiratory distress syndrome). 
 
a Presence of substantial symptoms of depression, anxiety and PTSD was defined by Hospital Anxiety and Depression Scale (HADS) depression 
and anxiety subscale scores >8 and an Impact of Event Scale – Revised (IES-R) score >1.6. Results are presented as prevalence ratios, calculated 
by Poisson regression models using generalized estimating equations (GEE) with robust variance estimate, an exchangeable correlation 
structure, and an indicator for time (12- vs. 6-month follow-up). 
b Variables included in multivariable analyses are those from bivariable analyses that were associated (at p <0.20) with each outcome measure of 
depression, anxiety, or PTSD symptoms.  
c All the significant associations (p<0.05) in multivariable models are highlighted in bold.  
d Age quartiles in years: 18-39 (quartile 1), 40-49 (quartile 2), 50-59 (quartile 3), 60-89 (quartile 4). Quartile 4 (60-89) was used as the reference 
group. 












Table 3. Variables associated with severity of psychiatric symptoms 
 Increase (95% CI) in psychiatric symptom scorea,b,c 
 HADS-Depression HADS-Anxiety IES-R 
Variables  Bivariable Multivariable Bivariable Multivariable Bivariable Multivariable 
Baseline patient data       
Age quartile (younger vs. 
older) d 
0.03 (-0.30, 0.36)  0.67 (0.34, 1.01) 0.70 (0.30, 1.10) 0.13 (0.07, 0.19) 0.14 (0.07, 0.21) 
Female 1.28 (0.57, 1.99) 0.91 (0.11, 1.71) 1.63 (0.90, 2.36) 1.81 (0.94, 2.67) 0.33 (0.19, 0.46) 0.38 (0.22, 0.54) 
White -0.13 (-1.06, 0.81)  0.24 (-0.72, 1.20)  -0.08 (-0.25, 0.09)  
Unemployed 2.04 (1.34, 2.75) 1.74 (0.95, 2.54) 1.30 (0.56, 2.04) 1.22 (0.36, 2.09) 0.21 (0.08, 0.35) 0.20 (0.05, 0.36) 
BMI, per 10 kg/m2  0.47 (0.03, 0.91) 0.15 (-0.35, 0.65) 0.33 (-0.12, 0.79) 0.39 (-0.16, 0.95) 0.06 (-0.02, 0.14) 0.10 (-0.01, 0.20) 
Diabetes 0.16 (-0.68, 1.00)  -0.39 (-1.26, 0.48)  -0.13 (-0.29, 0.02) -0.02 (-0.21, 0.17) 
Stroke 0.95 (-2.08, 3.99)  0.47 (-2.66, 3.61)  0.14 (-0.45, 0.73)  
Hemodialysis 0.42 (-2.01, 2.85) 0.82 (-1.91, 3.55) -0.92 (-3.42, 1.59) 0.03 (-3.06, 3.12) 0.19 (-0.26, 0.64)  
Alcohol misuse 0.55 (-0.34, 1.43)  0.88 (-0.04, 1.80) 1.88 (0.81, 2.95) 0.20 (0.03, 0.36) 0.40 (0.21, 0.60) 
Baseline intensive care 
data 
      
Admission to medical ICU 0.13 (-0.60, 0.85)  -0.01 (-0.75, 0.74)  -0.04 (-0.17, 0.10)  
APACHE III, per 20 unit  -0.39 (-0.67, -0.12) -0.36 (-0.68, -
0.03) 
-0.52 (-0.81, -0.23) -0.44 (-0.79, -
0.08) 
-0.06 (-0.11, -0.01) -0.07 (-0.13, -
0.01) 
PaO2/FiO2, per 20 unit  0.05 (-0.05, 0.15)  -0.01 (-0.12, 0.09)  0.00 (-0.02, 0.02)  
Sepsis as ARDS risk factor -0.41 (-1.25, 0.43)  -0.22 (-1.09, 0.65)  -0.12 (-0.27, 0.04) -0.03 (-0.23, 0.17) 
Daily intensive care data       
No. of organ failures -0.61 (-1.18, -0.04) -0.51 (-1.30, 0.28) -0.69 (-1.28, -0.11) -0.28 (-1.13, 0.57) -0.04 (-0.15, 0.07)  
Any hemodialysis -1.45 (-2.55, -0.35) -0.64 (-2.01, 0.74) -1.31 (-2.43, -0.18) -0.69 (-2.16, 0.78) -0.03 (-0.24, 0.17)  
Any vasopressor use -0.06 (-0.78, 0.65)  0.30 (-0.44, 1.04)  0.07 (-0.06, 0.21)  
% of days with opioids, 
per 20%  
0.41 (0.14, 0.67) 0.42 (0.16, 0.69) 0.39 (0.12, 0.67) 0.39 (0.10, 0.68) 0.09 (0.04, 0.13) 0.07 (0.02, 0.12) 
% of days with 
corticosteroids, per 20%  
0.09 (-0.14, 0.32)  0.08 (-0.16, 0.32)  0.03 (-0.01, 0.08) 0.02 (-0.02, 0.06) 
% of days with 
neuromuscular blocker, 
per 20%  
0.10 (-0.50, 0.70)  0.68 (0.07, 1.30) 0.67 (0.03, 1.31) 0.12 (0.01, 0.23) 0.14 (0.02, 0.25) 
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Morning glucose, per 20 
mg/dL  
0.01 (-0.27, 0.28)  -0.17 (-0.46, 0.11)  -0.01 (-0.07, 0.04)  
Minimum glucose, per 20 
mg/dL  
-0.13 (-0.48, 0.22)  -0.31 (-0.67, 0.06) -0.32 (-0.73, 0.10) -0.03 (-0.09, 0.04)  
Other intensive care data       
Mechanical ventilation 
duration, per week 
0.07 (-0.19, 0.33)  -0.07 (-0.34, 0.19)  0.02 (-0.03, 0.07)  
ICU length of stay, per 
week 
0.03 (-0.20, 0.26) 0.01 (-0.26, 0.27) -0.09 (-0.33, 0.14) -0.25 (-0.54, 0.05) 0.01 (-0.03, 0.06) -0.04 (-0.09, 0.01) 
Change at 12 vs. 6 month 
follow-up e 
 -0.01 (-0.35, 0.33)  -0.30 (-0.70, 0.09)  -0.06 (-0.14, 0.01) 
 
Abbreviations: CI (confidence interval), HADS (Hospital Anxiety and Depression Scale), IES-R (Impact of Event Scale – Revised), BMI (body mass 
index), ICU (Intensive Care Unit), APACHE III (Acute Physiology and Chronic Health Evaluation III), PaO2/FiO2 (ratio between partial pressure of 
oxygen in arterial blood and fraction of inspired oxygen), ARDS (acute respiratory distress syndrome). 
 
a Results are presented as the mean difference in HADS-depression, HADS-anxiety, and IES-R scores, calculated by linear regression models using 
generalized estimating equations (GEE), an exchangeable correlation structure, and an indicator for time (12- vs 6-month follow-up). 
b Variables included in multivariable analyses are those from bivariable analyses that were associated (at p < 0.20) with each outcome measure 
of psychiatric symptom score. 
c All the significant associations (p<0.05) in multivariable models are highlighted in bold.  
d Age quartiles in years: 18-39 (quartile 1), 40-49 (quartile 2), 50-59 (quartile 3), 60-89 (quartile 4). Quartile 4 (60-89) was used as the reference 
group. 





Chapter 3 – Section B Figures 







* Reasons for not completing psychiatric assessments at 6 and 12 months, respectively:  declined 8 and 
7, physically incapable 7 and 5, cognitively incapable 6 and 4, receiving mechanical ventilation 3 and 3, 
psychiatric issues 2 and 3, incarcerated 2 and 2, unable to contact 3 and 1, lack of time 0 and 1, and 









6 month follow-up: 
645 (98%) of 656 
Completed at least 1 psychiatric 
instrument: 613 (95%)
* 
Enrolled in ARDSNet trials 
1,176 
 
247 (21%) Dead at hospital discharge 
 
  44 (5%) Dead before re-consent 
  187 (20%)  Excluded, due to: 
     87 (9%)   Pre-existing cognitive impairment 
     41 (4%)   Non-English speaking 
     36 (4%)   Consent declined/withdrawn 
     21 (2%)   Homelessness 
       2 (<1%) <18 years old 
 
42 (6%) died before follow-up 
 
21 (3%) died before follow-up 
12 month follow-up: 
606 (95%) of 635 






Figure 2. Venn diagram of co-occurrence of anxiety, depression, and PTSD symptoms among 325 
patients with any psychiatric morbidity at 6-month follow-up. (Light grey area indicates co-occurrence 
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RATIONALE: Rehabilitation started early during an intensive care unit (ICU) stay is associated with 
improved outcomes and is the basis for many quality improvement (QI) projects showing important 
changes in practice. However, little evidence exists regarding whether such changes are sustainable in 
real-world practice. 
OBJECTIVE: To evaluate the sustained effect of a QI project on the timing of initiation of active physical 
therapy intervention in acute lung injury (ALI) patients. 
METHODS: This was a pre-post evaluation using prospectively collected data involving consecutive ALI 
patients admitted pre-QI (October 2004-April 2007, n=120) versus post-QI (July 2009-July 2012, n=123) 
from a single medical ICU. 
MEASUREMENTS AND MAIN RESULTS: The primary outcome was time to first active physical therapy 
intervention, defined as strengthening, mobility or cycle ergometry exercises. Among ICU survivors, 
more patients in the post-QI versus pre-QI group received physical therapy in the ICU (89% vs. 24%, 
p<0.001) and were able to stand, transfer or ambulate during physical therapy in the ICU (64% vs. 7%, 
p<0.001). Among all patients in the post-QI versus pre-QI group, there was a shorter median [IQR] time 
to first physical therapy (4 [2,6] vs. 11 days [6,29], p<0.001) and a greater median (IQR) proportion of 
ICU days with physical therapy after initiation (50% [33%,67%] vs. 18% [4%,47%], p=0.003). In 
multivariable regression analysis, the post-QI period was associated with shorter time to physical 
therapy (adjusted hazard ratio [95% confidence interval]: 8.38 [4.98,14.11], p<0.001), with this 
association significant for each of the 5 years during the post-QI period. The following variables were 
independently associated with a longer time to physical therapy: higher SOFA score (0.93 [0.89,0.97]), 
higher FiO2 (0.86 [0.75,0.99] for each 10% increase), use of an opioid infusion (0.47 [0.25,0.89), and 




CONCLUSIONS: In this single-site, pre-post analysis of ALI patients, an early rehabilitation QI project was 
independently associated with a substantial decrease in the time to initiation of active physical therapy 
intervention that was sustained over 5 years.  Over the entire pre-post period, severity of illness and 
sedation were independently associated with a longer time to initiation of active physical therapy 




















As short-term mortality for patients with acute lung injury (ALI) decreases,1-4 there is a growing 
population of survivors who frequently experience long-lasting physical impairments.5-10 Patients with 
ALI are often exposed to prolonged immobilization, contributing to neuromuscular weakness that has a 
negative impact on the survivors’ physical function and quality of life for years following discharge from 
the intensive care unit (ICU).6-11 Early rehabilitation, including physical therapy in the ICU, reduces 
neuromuscular weakness and improves physical function and quality of life in ALI survivors.12-20  
Despite evidence showing improved outcomes with early physical therapy in the ICU, many 
critically ill patients remain immobilized for prolonged periods, with initiation of physical therapy 
delayed until mechanical ventilation is discontinued and the patient is discharged from the ICU.14,19,21-25  
There are several potentially modifiable barriers to incorporating early physical therapy into routine 
clinical practice, including: inadequate multidisciplinary education, staffing and collaboration; 
insufficient knowledge; and deep sedation.16,21,24,26,27 Multiple centers have addressed such potential 
barriers to early physical therapy by successfully implementing structured quality improvement (QI) 
projects.28-36 These projects, along with clinical trials and observational studies, have demonstrated that 
early physical therapy in critically ill patients is safe and feasible.12-16,18,26,27,37-41 However, there is little 
published evidence assessing whether QI projects can be sustained beyond the period of their initial 
implementation and evaluation. Sustainability is an important aspect in evaluating QI interventions 
since, over time, clinician practice may revert to earlier routines when there is a focus on new areas of 
practice.42  
Hence, our objective is to evaluate the sustainability of an early rehabilitation QI project in a 
single medical ICU (MICU) and to evaluate how the QI project and other patient and ICU-related factors 






An early rehabilitation QI project was conducted from May to August 2007 at the Johns Hopkins 
Hospital MICU. This project aimed to reduce modifiable barriers to early rehabilitation interventions for 
all MICU patients.28,43 Details of this QI project are provided elsewhere28,43 and summarized herein. The 
QI project followed a pre-established structured methodology43,44 and included the following 
components: 1) changing the default MICU activity order from “bed rest” to “as tolerated”; 2) 
encouraging a change in sedation practice from continuous infusions to “as needed” boluses; 3) 
establishing simple guidelines for consultation to physical therapy; 4) establishing safety guidelines for 
initiating  early rehabilitation; and 5) full-time dedicated MICU rehabilitation therapist staffing.28 The 
project was planned and implemented via a multidisciplinary team that met weekly to discuss and 
evaluate the project. 
After evaluation of the QI project, the hospital administration funded an ongoing, early 
rehabilitation program starting the next fiscal year, July 2008 onwards. In addition to maintaining the QI 
project components described above, a new protocol for sedation management and delirium screening 
was implemented to formalize changes made during the QI project.45  Moreover,  to further promote 
sustainability, the multidisciplinary weekly meetings continued with a focus on identifying and 
addressing new barriers, evaluating individual patient needs, inspiring innovation in early rehabilitation 
practices,46-48 and continuing interdisciplinary education and collaboration with >20 physical therapists 
who worked in the MICU during the post-QI period. Moreover, safety events37,39 and mobility milestones 
continued to be evaluated with feedback provided, at least monthly, in the multidisciplinary meetings. 
Meetings with hospital administrators, highlighting the program’s successes and sustained reduction in 




To evaluate the sustainability of a change in the timing of initiation of active physical therapy 
intervention, we conducted a pre-post comparison study using prospectively collected data.  Data for 
the pre-QI control period was obtained from a prospective cohort study of consecutive ALI patients 
admitted to the Johns Hopkins MICU from October 2004 to April 2007.50 To evaluate the sustainability of 
the QI project, data for the post-QI period started one year after initiation of the early rehabilitation 
program (i.e. July 2009 onward). These data were obtained from a pre-existing clinical registry of 
consecutive patients admitted to the Johns Hopkins MICU from July 2009 until July 2012. For both the 
pre- and post-QI groups, all patients evaluated in this analysis were consecutive mechanically ventilated 
patients meeting the American-European Consensus Conference criteria for ALI.51 The prospective 
cohort study providing the pre-QI control group data excluded patients with any of the following 
characteristics: (1) pre-existing cognitive impairment, (2) non-English speaking, (3) life expectancy <6 
months due to a pre-existing illness, (4) limitations in care (e.g., an order for no vasopressors) at time of 
meeting ALI criteria, and (5) >5 days of mechanical ventilation prior to ALI or transfer from another ICU 
with pre-existing ALI (>24 hours). To ensure comparability, these same exclusion criteria were applied to 
the post-QI group. 
Primary Outcome 
The primary outcome is the time (in days) from ALI onset to initiation of active physical therapy 
intervention during the patient’s index MICU admission. We defined active physical therapy intervention 






Physiological abnormalities and potential safety events were not collected for the pre-QI period.  
These events were prospectively collected during the post-QI period and defined as any of the following: 
(1) removal, dislodgment, disruption, or dysfunction of airway, feeding tube, chest tube, vascular access, 
cardiac device, or wound dressing; (2) cardiopulmonary changes including arrhythmia, desaturation, and 
hyper- and hypotension, , (3) falls, (4) cardiac arrest, and (5) death.37 
Covariates  
Patient and ICU-related variables collected from the medical record were included in the 
analysis. Patient variables were age, sex, race, and body mass index (BMI). Baseline comorbidities were 
measured  using the Charlson52 and Functional53 comorbidity indices. ICU-related variables were ICU 
admission diagnosis category and the Acute Physiology and Chronic Health Evaluation II (APACHE II) 
score within the first 24 hours of ICU admission.54 Daily organ failure status was measured via Sequential 
Organ Failure Assessment (SOFA) score.55 Daily mechanical ventilation status, fraction of inspired oxygen 
(FiO2), and positive end-expiratory pressure (PEEP) data were collected from morning ventilator settings. 
Daily benzodiazepine and opioid infusion status were measured in addition to daily morning sedation 
and delirium status using the Richmond Agitation Sedation Scale (RASS) 56 and CAM-ICU,57 respectively. 
Patient sedation status was qualitatively classified as follows:  awake (RASS ≥ -1), lightly sedated (RASS -
2 or -3) or deeply sedated/comatose (RASS -4 or -5). 
Statistical analyses 
Patient and ICU-related variables were compared between the pre-QI and post-QI groups using 
Pearson’s chi-square, Fisher’s exact, or Wilcoxon rank-sum tests as appropriate. Sedation and delirium 




staff.  Hence, missing data (e.g. due  to lack of staff coverage on weekends or during holidays) were 
imputed using multiple imputation58 (with five datasets) as described elsewhere.59   
We compared time to initiation of active physical therapy intervention for patients admitted to 
the MICU during the post-QI versus pre-QI periods. Bivariable associations of patient and ICU-related 
variables with time to initiation of active physical therapy intervention were evaluated using Fine and 
Gray proportional sub-distribution hazards regression analysis. The Fine and Gray method was used to 
account for the competing risk of mortality while analyzing associations of patient and ICU 
characteristics with the time to first physical therapy intervention.60 To evaluate for violations of the 
proportionality assumption in the regression analysis, Schoenfeld residuals were plotted versus 
functions of time.61 Covariates with a bivariable association with time to first physical therapy 
intervention of p<0.150 were included in the multivariable Fine and Gray regression model.  
Multicollinearity was assessed in the multivariable regression model using variance inflation 
factors.62 This analysis demonstrated that daily delirium status was strongly collinear with daily sedation 
status, and therefore delirium status was excluded from the final regression model. Cumulative 
incidence function curves were created by first fitting the final multivariable regression model to each of 
the five imputed sedation status datasets and obtaining the average cumulative incidence of initiation of 
active physical therapy intervention.  
We assessed for statistical interaction between admission during the post-QI period and the 
following clinically relevant covariates based on a priori hypotheses: age, BMI, APACHE II score, SOFA 
score, mechanical ventilation status, FiO2, PEEP, and sedation status. Statistical analyses were 
performed using STATA 12.0 software (Stata Corporation, College Station, TX).  Statistical significance 






Patients in the pre-QI (n=120) versus post-QI (n=123) periods were similar in most demographic 
and ICU-related variables (Table 1). Across the entire patient cohort (n=243), 52% were female, with a 
median (inter-quartile range [IQR]) age and APACHE II score of 49 [40 – 59] years and 29 [24, 35], 
respectively. Moreover, among all patients, 92% had a PaO2/FiO2 <200 (46% had PaO2/FiO2 <100) at 
ALI onset, and a median [IQR] daily average PEEP of 6.9 cmH2O [5.0, 9.3]. ICU mortality was 45% (not 
significantly different in post-QI versus pre-QI:  41% versus 48%, p=0.282). In the post-QI versus pre-QI 
period, patients were more frequently admitted from an outside hospital (34% vs. 18%), and  patients 
were less sedated with a higher median [IQR] daily average RASS score (-2.1[-3.5,-1.0] vs. -3.2[-4.3,-2.4], 
p<0.001) and lower median [IQR] proportion of ICU days on a benzodiazepine infusion (50% [0,100] vs. 
72% [49,100], p<0.001) and with deep sedation/coma (33% [0,70] vs. 60% [38,88], p<0.001). 
Among all patients, 68% in post-QI and 16% in pre-QI group ever received physical therapy 
(Table 2).  Moreover, those in the post-QI versus pre-QI group had a shorter median [IQR] time to first 
physical therapy intervention (4 [2,6] vs. 11 [6,29] days, p<0.001), greater median [IQR] proportion of 
ICU days with physical therapy after its initiation (50% [33,67] vs. 18% [4,47], p=0.003), and a greater 
proportion of patients achieving a highest daily activity level of standing, transferring and/or ambulating 
during physical therapy treatment in the ICU (41% vs. 4%, p<0.001) (Table 2). When restricting analyses 
to those surviving until ICU discharge, the median [IQR] time to first physical therapy intervention 
remained shorter in the post-QI versus pre-QI group (4 [2,6] vs. 12 [6.29], p<0.001), and an even greater 
proportion of patients in the post-QI versus pre-QI group ever received physical therapy in the ICU (89% 
vs. 24%, p<0.001) and achieved a highest daily activity level of standing, transferring and/or ambulating 
in the ICU (64% vs. 7%, p<0.001). There were no prospectively recorded physiological abnormalities or 




In regression analysis, the post-QI period was independently associated with a shorter time to 
initiation of active physical therapy intervention (adjusted hazard ratio (HR) [95% CI]:  8.38 [4.98, 14.11], 
p<0.001) (Table 3) (Figure 1). In a post-hoc analysis, this association with a shorter time to physical 
therapy was similar for each year within the 5-year post-QI period.  Among ICU-related variables 
(analyzed as time-varying daily exposures), the following were significantly associated with longer time 
to initiation of active physical therapy intervention (adjusted HR, [95% CI]): higher SOFA score (0.93 
[0.89, 0.97], p<0.001), higher FiO2 (0.86 [0.75, 0.99] for a 10% increase, p=0.038), any opioid infusion 
(0.47 [0.25, 0.89], p=0.021), and deep sedation/coma (0.24 [0.12, 0.46], p<0.001). None of the a priori 
selected exposures (BMI, APACHE II score, SOFA score, mechanical ventilation status, FiO2, PEEP, and 
sedation status) had any significant statistical interaction with the post-QI (vs. pre-QI) period and its 
association with timing of initiation of active physical therapy intervention in the ICU. 
Discussion 
In this single site, pre-post evaluation of 243 patients predominantly with moderate or severe 
ALI, an early rehabilitation QI project was independently associated with a large and statistically 
significant decrease in the time to initiation of active physical therapy intervention, and this association 
was sustained for 5 years after completion of the QI project. There was no modification of the 
association between admission during the post-QI period and earlier initiation of active physical therapy 
intervention by any patient or ICU-related factors. Increased severity of illness and hypoxia, any opioid 
infusion and deep sedation were independently associated with delayed initiation of active physical 
therapy intervention in the MICU. 
To our knowledge, this is the first report of the sustainability of an ICU-based early rehabilitation 
QI project. Similar to prior publications on the implementation of successful QI projects, our MICU 




executing the QI project.26 This culture change included education on the importance and success of 
early rehabilitation in the ICU, implementation of simple guidelines to ensure safe and timely referral to 
PT, and improved multidisciplinary communication and clinical care. This report is novel because it 
demonstrates these changes can be incorporated into routine clinical practice across more than 20 
physical therapists providing clinical care in the MICU, thereby contributing to successfully sustaining 
early rehabilitation long after completion of a QI project. 
The time to initiation of active physical therapy intervention was significantly shorter in the 
post- versus pre-QI period (4 vs. 11 days) but longer than the 1.5 days reported in a randomized 
controlled trial (RCT) of 104 mechanically ventilated MICU patients.14 There are important distinctions 
between these two study designs that may account for this difference. The general aim of RCTs is to 
establish efficacy of an intervention, typically in the context of a resource-intensive research 
environment with a highly selected subset of consenting patients. These circumstances may not reflect 
routine clinical practice that is evaluated in quality improvement projects.42,63 For instance, in our 
evaluation versus the RCT, patients without baseline functional independence were not excluded and 
severity of illness was substantially higher as reflected by median APACHE II scores (29 vs. 20) and 
proportion of participants with moderate or severe ALI (92% versus 55%).  
Of those surviving until ICU discharge, 89% of patients in the post-QI group received physical 
therapy in the ICU, similar to the previously described RCT, in which 94% (46/49) of patients received 
physical therapy and occupational therapy in the ICU.14 Likewise, in another evaluation of an early 
mobility protocol including 116 mechanically ventilated MICU patients, 91% received physical therapy in 
the ICU.19 Among patients in the pre-QI control period in our evaluation, 16% ever received physical 
therapy in the ICU and 4% were mobilized out of bed. These findings are similar to other evaluations of 




Germany, 8% of patients with an endotracheal tube were mobilized out of bed.25 Moreover, in another 
point prevalence study of 514 patients in 38 New Zealand and Australian hospitals, no mechanically 
ventilated patients were mobilized out of bed.23 Finally, the control groups of ICU rehabilitation studies 
of mechanically ventilated patients22 have demonstrated that 13% of mechanically patients received 
physical therapy in the ICU19 and the median (IQR) duration of PT and OT in the ICU was 0 (0, 0) 
minutes.14  
Two non-modifiable risk factors, severity of organ failure and hypoxia, were associated with 
delayed initiation of physical therapy. In prior studies, increased organ failure24,64 and physiologic 
instability25 were associated with delayed initiation of physical therapy, and respiratory instability also 
has been as a barrier to early mobilization.21 Importantly, despite a high severity of illness in the post-QI 
patients, early physical therapy was initiated without the occurrence of any prospectively-evaluated and 
defined major physiological abnormalities or potential safety events. These findings support existing 
literature demonstrating the safety of early rehabilitation in critically ill patients.12-14,18,19,23,37,38 
In our analysis, there were two modifiable risk factors independently associated with delayed 
initiation of physical therapy:  deep sedation and receiving an opioid infusion. Sedation is a known 
barrier to physical therapy in critically ill patients.16,21,25 In the current study, a sedation protocol was 
implemented coincident with the early rehabilitation program in order to reduce this modifiable barrier 
to physical therapy.45 Such pairing of an early rehabilitation program with a sedation protocol is 
common in other studies of ICU rehabilitation interventions.14,28,65 Despite adjusting for differences in 
sedation practice between pre- and post-QI periods, admission during the post-QI period remained 
significantly associated with earlier initiation of physical therapy. 
There are possible limitations to this study. Because this was an observational pre-post 




time to initiation of physical therapy, and residual confounding may influence the results. Nonetheless, 
our findings are consistent with prior RCTs evaluating early rehabilitation in critically ill patients14,18 and 
reports of barriers to mobilization.13,16,17,21 Moreover, the study population consisted solely of ALI 
patients in an adult MICU within a single academic hospital. Therefore, the findings may not be 
generalizable to other populations and settings. However, ALI patients are the archetype of severely 
critically ill patients; thus, supporting the generalizability of our findings to populations with a similar or 
lesser severity of illness.19,29-36 
In conclusion, an early rehabilitation QI project was independently associated with a substantial 
decrease in the time to initiation of physical therapy intervention that was sustained for five years after 
project completion. The association between the post-QI rehabilitation program and earlier initiation of 
physical therapy was not modified by patient-related or ICU-specific factors. Modifiable factors 
independently associated with delayed initiation of physical therapy included opioid infusions and deep 
sedation, while severity of organ failure and hypoxia were non-modifiable patient risk factors for 
delayed initiation. These findings may help inform new and existing rehabilitation programs regarding 
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Chapter 4 – Section A Tables 








Age, median (IQR), years 49 (40, 59) 48 (40, 57) 51 (37, 63) 0.163 
Female, n (%) 127 (52) 57 (47) 70 (57) 0.142 
White race, n (%) 106 (44) 47 (39) 59 (48) 0.167 
BMI, median (IQR) 26 (22, 32) 27 (23, 32) 26 (22, 32) 0.601 
BMI ≥30, n (%) 97 (40) 43 (36) 54 (44) 0.238 
Charlson comorbidity index, median (IQR) 2 (1, 4) 3 (1, 5) 2 (0, 4) <0.001 
Functional comorbidity index, median 
(IQR) 
1 (1, 3) 1 (1, 2) 1 (1, 3) 0.164 
ICU admission source, n (%)    0.025 
Emergency room 63 (26) 33 (28) 30 (24)  
Ward 106 (44) 61 (51) 45 (37)  
Other ICU 10 (4) 4 (3) 6 (5)  
Other hospital  64 (26) 22 (18) 42 (34)  
ICU admission diagnosis, n (%)    0.069 
  Respiratory (including pneumonia) 149 (61) 80 (67) 69 (56)  
  Sepsis/infectious disease 47 (19) 18 (15) 29 (24)  
  Gastrointestinal 25 (10) 14 (12) 11 (9)  
  Cardiovascular 6 (2) 4 (3) 2 (2)  
  Central nervous system 4 (2) 2 (2) 2 (2)  
  Other 12 (5) 2 (2) 10 (8)  
APACHE II at ICU admission, median (IQR) 29 (24, 35) 29 (23, 36) 29 (25, 35) 0.906 
SOFA-Respiratory score Day 1, median 
(IQR) 
3 (3, 4) 4 (3, 4) 3 (3, 4) 0.079 
PaO2/FiO2 on Day 1, n (%)    0.109 
≥200  20 (8) 10 (9) 10 (9)  
≥ 100 & <200 105 (46) 46 (39) 59 (52)  
<100 105 (46) 61 (52) 44 (39)  
Mean daily SOFA score, median (IQR) 10 (6 ,14) 10 (6, 15) 10 (7, 13) 0.980 
Proportion of ICU days on mechanical 
ventilation, median (IQR) 
83 (67, 95) 80 (67, 91) 86 (67, 100) 0.047 
Average FiO2, median (IQR) 54 (44 ,67) 52 (43, 63) 56 (47, 68) 0.065 
Average PEEP, median (IQR) 6.9 (5.0, 9.3) 6.7 (5.0, 9.3) 7.3 (5.0, 9.3) 0.322 
Proportion of ICU days on 
benzodiazepine infusion, median (IQR) 
60 (29, 100) 72 (49, 100) 50 (0, 100) <0.001 
Proportion of ICU days on opioid infusion, 
median (IQR) 
74 (39, 100) 80 (50, 100) 67 (14 ,100) 0.056 
Average RASS, median (IQR)e -2.9 (-3.9, -1.7) -3.2 (-4.3, -2.4) -2.1 (-3.5, -1.0) 0.001 
Proportion of ICU days, median (IQR)e     
Awake 26 (0, 50) 21 (2, 40) 33 (0, 67) 0.093 




Deeply sedated/comatose 51 (17, 81) 60 (38, 88) 33 (0, 70) <0.001 
Proportion of ICU days with  delirium, 
median (IQR)e 
32 (10, 56) 25 (9, 42) 43 (17, 75) 0.008 
Abbreviations: QI, quality improvement; IQR, interquartile range; BMI, body mass index; ICU, intensive care 
unit; APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure 
Assessment; PaO2, arterial partial pressure of oxygen;FiO2, fraction of inspired oxygen; PEEP, positive end-
expiratory pressure; RASS, Richmond Agitation Sedation Scale 
aPercentages may not equal 100 due to rounding. 
bAll time-varying data, except when indicated as Day 1 of acute lung injury (ALI), are from date of ALI to date 
of first PT or ICU discharge. 
cMissing Data pre-QI/post-QI: BMI 2/20; Day 1 Sofa Respiratory Score (P/F) 3/10; FiO2 1/6; PEEP 1/9; RASS 
0/3 
dComparing pre-QI and post-QI groups and calculated using Pearson’s chi-square, Fisher’s exact, and 
Wilcoxon rank-sum tests, as appropriate 
ePatient sedation status was classified as follows:  awake (RASS ≥ -1), lightly sedated (RASS -2 or -3) or deeply 
sedated/comatose (RASS -4 or -5). Five imputed datasets were used to address missing data for RASS and 
CAM-ICU in the pre-QI group; the data presented represents the mean value for the median (IQR) of the 5 





Table 2.  Active physical therapy intervention in the medical intensive care unit, before and after a 





Ever receiving active PT intervention, n (%) 19 (16) 84 (68) <0.001 
Days to first active PT intervention, median (IQR) 11 (6, 29) 4 (2, 6) <0.001 
Number of PT sessions in index MICU admission, median (IQR) 0 (0, 0) 3 (0, 5) <0.001 
Percent ICU days with PT session, median (IQR) 0 (0, 0) 23 (0, 43) <0.001 
Percent ICU days with PT session after initiation, median (IQR) 18 (4, 47) 50 (33, 67) 0.003 
Physiological abnormality or potential safety events, n 
(percent of PT treatment sessions) b 
-- 0 (0%) N/A 
Highest daily activity during PT session during ICU stay, n (%)   <0.001 
Lying or sitting in bed 113 (94) 60 (49)  
Sitting at edge of bed 3 (3) 13 (11)  
Standing or transfer to chair 3 (3) 28 (23)  
Walking 1 (1) 22 (18)  
Abbreviations: ICU, intensive care unit; QI, quality improvement; PT, physical therapy; IQR, inter-quartile 
range; ICU, intensive care unit 
a Calculated using Pearson’s chi-square, Fisher’s exact, and Wilcoxon rank-sum tests, as appropriate 
b Safety events were not collected for the Pre-QI period.  Safety events were prospectively collected 
during the post-QI period and defined as any of the following: (1) removal, dislodgment, disruption, or 
dysfunction of airway, feeding tube, chest tube, vascular access, cardiac device, or wound dressing; (2) 
cardiovascular/hemodynamic instability that includes hyper- and hypotension, desaturation, cardiac 






Table 3: Factors associated with time to initiating physical therapy in the medical intensive care unit 
 Unadjusted
a  Adjusteda 
 
Hazard 




Ratio 95% CI 
p-
value 
Age, years 1.00 
0.99 – 
1.02 
0.523     
Male 0.90 
0.62 – 
1.31   
0.576     
White (versus non-white) 1.33 
0.92 – 
1.93 
0.134  1.14 0.78 – 1.68 0.496 




0.059  0.71 0.48 – 1.06 0.096 
Charlson comorbidity index 0.91 
0.83 – 
0.98 
0.020  0.97 0.91 – 1.04 0.400 
Functional comorbidity index 1.04 
0.93 – 
1.16 
0.471     









Source of ICU admission        




0.945     
Other ICU 1.34 
0.54 – 
3.32 
0.525     
Other hospital 1.28 
0.76 – 
2.14 
0.351     
ICU admission diagnosis        
  Respiratory (including 
pneumonia) 
1.00       
  Sepsis/infectious disease 0.84 
0.53 – 
1.33 
0.453     
  Gastrointestinal 0.56 
0.28 – 
1.11 
0.096     
  Cardiovascular 0.37 
0.05 – 
2.56 
0.311     
  Central nervous system 1.33 
0.29 – 
6.22 
0.714     
  Other 1.64 
0.70 – 
3.83 
0.256     
APACHE II at ICU admission 0.98 
0.96 – 
1.00 
0.088  0.99 0.97 – 1.02 0.595 
Daily SOFA score 0.90 
0.87 – 
0.93 
<0.001  0.93 0.89 – 0.97 0.001 
Daily mechanical ventilation status 0.34 
0.20 – 
0.58 
<0.001  0.83 0.41 – 1.71 0.614 
FiO2 received  (every 10%  increase) 0.69 
0.62 – 
0.78 





a  Adjusteda 
 
Hazard 










<0.001  0.99  0.91 – 1.08 0.812 
Benzodiazepine infusion 0.23 
0.15 – 
0.35 
<0.001  0.90 0.44 – 1.86 0.778 
Opioid infusion 0.25 
0.16 – 
0.37 
<0.001  0.47 0.25 – 0.89 0.021 
Sedation Statusb        
Awake 1.00    1.00   
Light sedation 0.56 
0.27 – 
1.16 
0.109  0.66 0.41 – 1.04 0.077 
Deep sedation/Comatose 0.09 
0.05 – 
0.17 
<0.001  0.24 0.12 – 0.46 <0.001 
Abbreviations: ICU, intensive care unit ; CI, confidence interval; BMI, body mass index; APACHE II, Acute 
Physiology and Chronic Health Evaluation II; SOFA, Sequential Organ Failure Assessment; FiO2, fraction 
of inspired oxygen; PEEP, positive end-expiratory pressure 
aHazard ratios greater than 1 indicate an association with earlier initiation of active physical therapy in 
the MICU.  Hazard ratios were calculated using Fine and Gray regression models,60 with daily time-
varying exposures for SOFA score, mechanical ventilation status, FiO2, PEEP, benzodiazepine infusion, 
opioid infusion, and sedation status. 
bPatient sedation status was classified as follows:  awake (RASS ≥ -1), lightly sedated (RASS -2 or -3) or 

















Chapter 4 – Section A Figures 
Legends: 
Figure 1. Probability of active physical therapy intervention in the medical intensive care unit in the 




Abbreviations: QI, quality improvement; PT, physical therapy;  ALI, acute lung injury.  
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Background: Guidelines support non-pharmacologic management, including cognitive stimulation, to 
address intensive care unit (ICU) delirium.  
Objectives: To qualitatively evaluate barriers and facilitators to cognitive stimulation, as part of a 
structured quality improvement (QI) project, in a medical ICU (MICU). 
Methods: Themes arising from semi-structured interviews with MICU nurses were categorized using the 
Consolidated Framework for Implementation Research (CFIR).  
Results: Twenty-three MICU nurses identified 62 barriers to cognitive stimulation and 26 facilitators. 
The resulting 12 barrier and 9 facilitator themes corresponded to the CFIR domains: Intervention 
Characteristics, Outer Setting, Inner Setting, Characteristics of Individuals, and Process. Patient-specific 
variables (e.g. sedation) were most frequently reported. Other barriers included: cognitive stimulation 
not a priority; nurse staff barriers; documentation burden; and lack of appreciation for evidence 
supporting cognitive stimulation. 
Conclusions: Barriers to cognitive stimulation in the MICU arise from the organization, context and 













Delirium occurs in up to 80% of mechanically ventilated and 50% of non-mechanically ventilated 
patients during their intensive care unit (ICU) stay.1 In these patients, delirium is associated with worse 
outcomes, including increased duration of mechanical ventilation and length of stay2-6 and greater 
cognitive impairment at one year after discharge.7,8 Hence, the prevention and treatment of delirium is 
important to improve outcomes for critically ill patients.  
 
Several recent studies have shown no benefit of pharmacologic therapy in preventing or treating 
delirium in critically ill patients,9-11 and the recently updated Society of Critical Care Medicine (SCCM) 
“Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, 
Immobility, and Sleep Disruption” (SCCM PADIS Guidelines) do not support the routine use of 
antipsychotics to manage delirium in the ICU. However, the guidelines do support the use of multi-
component, non-pharmacologic interventions, including cognitive stimulation, to manage delirium.12  
 
A pilot randomized controlled trial (RCT) in 140 non-mechanically ventilated ICU patients demonstrated 
that an early occupational therapy (OT) intervention (vs. usual care) decreased the incidence of delirium 
(3% vs. 20%, p< 0.001) and the proportion of study days with delirium (1% vs. 8%).13 Early OT involved 
two 40-minute sessions each day of a multi-component intervention including cognitive stimulation, 
which consisted of a notebook with tasks aimed at activating mental functions (e.g. alertness, visual 
perception, problem solving, etc).13 Meta-analyses have demonstrated that similar, multi-component 
non-pharmacologic delirium interventions are consistently associated with decreased incidence of 
delirium in both general medical/surgical and critically ill patients.14,15 Inspired by these studies, we 
commenced a structured quality improvement (QI) project to introduce cognitive stimulation, 




Understanding barriers to implementation is an essential component of translating evidence into 
practice.16 Therefore, the current project aimed to evaluate, using qualitative methods, potential 
barriers and facilitators to implementation of a cognitive stimulation intervention in an academic MICU 
in North America. 
 
Methods: 
QI project and planning 
Starting in September 2017, a QI project was undertaken to implement combined cognitive stimulation 
and early, goal-directed mobility, performed by nurses, in the [site de-identified] MICU. Notably, the 
[site de-identified] MICU had already incorporated many aspects of the above-mentioned multi-
component pharmacologic interventions, including early physical and occupational therapy, sedation 
protocol and reorientation, into routine care based on existing evidence. With the emergence of newer 
evidence,12-14 the decision was made to include cognitive stimulation as well. The planning and 
preparation for the MICU QI project (which is currently on-going) started in November 2016 and 
included establishment of a multidisciplinary team (including nurses, advanced practice providers, 
physicians, clinical technicians, physical and occupational therapists, and respiratory therapists). This 
project was reviewed by the [site de-identified] Institutional Review Board and was designated as 
quality improvement with a waiver of consent. 
 
Cognitive stimulation consisted of nurses reviewing a workbook of evidence-based tasks (focused on 
“alertness, visual perception, memory, calculus, problem solving, praxis, and language”)13 with patients 
(Richmond Agitation Sedation Scale Score -2 to +2) to reduce the incidence and duration of delirium in 
critically ill patients. While in a prior study cognitive stimulation was implemented by occupational 




basis as part of routine care. Preparation for the QI project included establishment of seven nursing 
super-users who then educated and trained the nursing staff on administration and then documentation 
of cognitive stimulation in the electronic medical record (EMR) using the following options: yes, no or 
not applicable. Approximately three months after launching the QI project, documentation of cognitive 
stimulation was noted to be low (~30%), thus making it challenging to infer implementation rate as well. 
Therefore, the multi-disciplinary QI team decided to qualitatively evaluate the potential barriers to 
nurse-driven cognitive stimulation by conducting semi-structured interviews with MICU nurses.  
 
Development of Interview Guide 
The interview guide was initially developed by a member of the QI team (AMP) with expertise in 
qualitative research, and then reviewed and revised with input from all members of the multidisciplinary 
quality improvement team before any nurses were approached. The final interview guide consisted of 5 
questions (Table 1) with probing, as needed, and based on the judgment of the interviewers.  
 
Interview process 
Beginning in October 2018 and continuing into December 2018, using purposive sampling, the 
interviewer approached bedside nurses. Day shift nurses were approached in the mid-afternoon while 
night shift nurses were approached about one hour before shift change in order to avoid the busiest 
times of the shift. Interviews took place in the MICU either at the work desk outside of patient rooms or 
at the nursing stations. The initial four interviews were conducted by a physician member of the team 
(AMP) who then trained an additional physician (LA) to assist with the remaining interviews. In order to 
encourage nurses to respond openly about perceived barriers, 1) physician members of the QI team 
were selected to conduct the interviews since they were not direct nursing supervisors, and 2) the 




transcribed verbatim. Instead, interviewers recorded detailed field notes, including nurses’ responses to 
questions, points of clarification, interviewer reflection on nurses’ responses and any other details that 
were perceived as potentially relevant.  
 
Coding and Development of Themes 
Initially, nurses were asked questions regarding barriers to implementation of cognitive stimulation in 
the MICU. However, many nurses also discussed facilitators, and so the codebook included both barriers 
and facilitators to cognitive stimulation implementation. Coding was conducted by a member of the QI 
team (AMP) with expertise in qualitative research methods who then trained two additional reviewers 
(LA and NA) and performed quality assurance. Using thematic analysis, two reviewers (LA and NA) 
independently read the field notes line by line to inductively create a codebook.17-19 For the initial round 
of coding, the second coder coded the first seven interviews in reverse order. After coding the first 
seven interviews, three team members (AMP, LA, NA) met in person to evaluate for the emergence of 
themes. Interviews continued with concurrent coding by two independent reviewers (LA and NA) with 
discrepancies resolved by a third reviewer (AMP). After every three to five interviews, the codebook was 
updated and reviewed for potential coding saturation. Coding saturation was achieved after 20 
interviews, and three more interviews were conducted to confirm coding saturation, with a total of 23 
interviews completed. The codebook was then updated and reviewed by all three reviewers to confirm 
completeness. Two independent reviewers (LA and NA) then independently coded each transcript with a 
third reviewer resolving discrepancies (AMP). The barriers and facilitators were summarized into themes 
which were subsequently mapped using the Consolidated Framework for Implementation Research 
(CFIR), a set of constructs that allow for systematic and comprehensive evaluation of implementation.15 
The five CFIR domains include: intervention characteristics, outer setting, inner setting, characteristics of 




confirmed for completeness and accuracy with three MICU nurses as a means of member checking, a 
strategy used to evaluate the reliability of qualitative data.21 Three independent reviewers (LA, NA, 
AMP) assigned each barrier to a CFIR construct, with discrepancies resolved by group consensus. This 
qualitative project is reported using the Consolidated Criteria for Reporting Qualitative Research 




Interviews were conducted with 23 MICU nurses. All nurses agreed to participate. Seventeen (74%) of 
the nurses interviewed were women, and 12 nurses (61%) were on day shift at the time of the 
interview. Nurses had been in the profession for a mean (standard deviation (SD)) of 9 (9) years and 
working in the [site de-identified] MICU for 6 (7) years. Each 5-question semi-structured interview took 
up to ten minutes to complete.  
 
Twenty-two out of 23 (96%) nurses were aware of the QI project and had attempted cognitive 
stimulation with at least one patient and identified multiple barriers to cognitive stimulation in the 
MICU. Nineteen (83%) nurses identified at least one facilitator for implementation of cognitive 
stimulation in the MICU.   
 
Descriptions of Barriers and Facilitators 
Nurses identified a total of 62 barriers to cognitive stimulation implementation as well as 26 facilitators. 
These were further summarized into 12 barrier (Table 2) and 9 facilitator (Table 3) themes that were 
subsequently mapped to the CFIR domains and constructs. Exemplar statements are reported in Tables 





CFIR Intervention Characteristics 
Ten nurses (43%) reported that the current method (free-text entry) for documentation of cognitive 
stimulation in the EMR was a barrier to implementation. Nurses stated that having a designated section 
in the EMR that included drop-down lists would facilitate implementation.  
 
Some nurses commented on the adaptability of the cognitive stimulation intervention, suggesting it 
might be more appealing to some patients if it could be delivered via an electronic tablet. Similarly, 
nurses believed the intervention could be improved by translating it into other languages for use by 
non-English-speaking patients. 
 
CFIR Outer Setting 
Patient-specific variables were the most frequently reported barriers to cognitive stimulation (reported 
by 20 nurses (87%)). Nurses stated that some patients were not cooperative with cognitive stimulation 
because they did not like the workbook or due to sedation, pain, agitation, or fatigue. Among these, 
sedation was the most commonly cited barrier. While some nurses described apprehension over even 
offering the packet because of perceived patient opposition, others said that patients clearly declined to 
participate in cognitive stimulation. One nurse described that while she was sometimes concerned she 
might offend patients by asking them to complete the relatively simple tasks, she would address this 
potential barrier by explaining the reasoning for cognitive stimulation to patients who were reluctant to 





Nurses also pointed out that cognitive stimulation using the packet could be more challenging for 
patients who were non-English speaking or hearing or vision impaired or had difficulty using their hands. 
At least one nurse described lack of family support for cognitive stimulation. 
 
CFIR Inner Setting 
Seventeen (74%) nurses reported that the current MICU climate did not support cognitive stimulation as 
a relative priority. For example, one nurse reported: Sometimes it feels it’s less of a priority than other 
tasks, especially in the ICU. Similarly, night shift nurses believed patients’ sleep was a priority and thus, 
cognitive stimulation should be administered during day shift only. Nurses also referred to staff barriers 
to implementing cognitive stimulation, including the overall workload, staff turnover and lack of patient 
continuity. A representative statement was:  Any task that doesn’t have specialists falls on nurses. 
Overall burden of documentation was also cited as a barrier to implementation of cognitive stimulation. 
 
Other nurses felt the MICU culture was one that supported QI projects or research focused on improving 
patient care and described how this culture facilitated implementation of cognitive stimulation. These 
nurses often compared the current QI project involving cognitive stimulation to a prior structured QI 
project in the same MICU that focused on reducing sedation and delirium.18 
 
Packet availability was also a barrier to implementation with nurses reporting that packets were 
unusable or sometimes missing from patient rooms altogether. 
 
CFIR Characteristics of Individuals 
Ten (43%) nurses described an incomplete understanding of the evidence supporting cognitive 




implementation. Moreover, some nurses were reluctant to engage patients perceived as having no 
cognitive impairment in cognitive stimulation because they worried such patients would be offended by 
what the nurses perceived as simple task. Other nurses reported that their appreciation for the benefits 
of cognitive stimulation and the importance of preventing and treating delirium motivated their efforts 
to engage patients in cognitive stimulation. Only two nurses acknowledged lack of familiarity with the 
packet, especially among new or travel nurses, as a barrier to administering cognitive stimulation. 
 
CFIR Process 
While there were no barriers to cognitive stimulation identified within the CFIR domain “Process”, 
nurses did suggest several potential facilitators within this domain. Nurses frequently referred to 
existing multidisciplinary education and training regarding administration and documentation of 
cognitive stimulation as facilitators for implementation. Some nurses stated more training was needed 
and suggested a process for periodic re-education. Moreover, at least one nurse felt it would be helpful 
to train families to assist with cognitive stimulation. 
 
Nurses had several ideas regarding incorporation of cognitive stimulation into their daily workflow 
(Table 3). Nurses suggested administering cognitive stimulation and completing the documentation 
along with assessments of cognition, including the Confusion Assessment Method for the ICU (CAM-
ICU)23 and Richmond Agitation-Sedation Scale (RASS).24  
 
Nurses reported that reminders to administer and document cognitive stimulation facilitated 






Results of Member Checking 
Overall, three nurses agreed that the barrier and facilitator themes were representative of the nurses’ 
thoughts regarding cognitive stimulation. They emphasized the overall desire for more autonomy in 
delivery of the intervention, including via the addition of more complicated tasks for patients who were 
cognitively intact and the option to use an electronic tablet to administer cognitive stimulation (see CFIR 
Process above and Table 3).  
 
Discussion: 
Through this qualitative project evaluating implementation of cognitive stimulation in an academic 
MICU in North America, nurses identified 62 barriers and 26 facilitators which could be summarized into 
12 barrier and 9 facilitator themes corresponding to each of the CFIR domains. Barrier and facilitator 
themes arose from the organization, context and individuals associated with the intervention as well as 
the intervention itself, while nurses identified potential facilitators within the implementation process 
(“engaging”).     
 
Identifying barriers to implementation is an important step in the QI process,16 and a critical aspect of 
intervention implementation. The most commonly cited barriers to cognitive stimulation were patients 
declining or lack of cooperation due to sedation, pain, agitation, fatigue or disinterest and fell within the 
CFIR domain “outer setting” and the construct “patient needs and resources”.20 Sedation was the most 
frequently cited reason for patients’ inability to cooperate with cognitive stimulation. This is consistent 
with evaluations of barriers to other ICU-based interventions, including early mobility and delirium 
assessments. A systematic review, including 40 studies, identified “patient-related” barriers as the most 
commonly reported barriers to early mobilization of critically ill patients, and among these, sedation was 




regarding delirium assessments, using a survey administered to 331 nurses demonstrated that sedation 
was one of the more commonly reported barriers to delirium assessment.26 Sedation might be an 
appropriate contraindication to cognitive stimulation as some patients require deep sedation for severe 
acute respiratory distress syndrome or other medical conditions. However, in other instances, there 
might be an opportunity for improved sedation practices, similar to those first fostered by a structured 
QI project in the [site de-identified] MICU, which aimed to decrease sedation and delirium using a 
sedation protocol and was indeed associated with increased wakefulness.27  
 
Another frequently reported barrier, corresponding to the CFIR domain “characteristics of individuals” 
and construct “knowledge and beliefs about the intervention”, involved nurses’ perception of some 
patients as cognitively intact (or not delirious) and thus not likely to benefit from cognitive stimulation. 
This raises two important issues regarding the management of delirium in ICU patients. First, delirium 
and associated cognitive impairment is substantially under-recognized in the ICU by nurses and 
physicians. A study following 46 patients over 425 patient days, using the CAM-ICU as the reference 
standard for delirium assessment, showed that nurses and physicians detected only 35% and 28% of 
delirium-days, respectively.28 Second, cognitive stimulation may prevent the development of delirium in 
critically ill patients who appear otherwise cognitively intact,13 and primary prevention is likely the most 
effective strategy for reducing the complications associated with delirium.29 Indeed, in a study of over 
800 older hospitalized patients, a multicomponent intervention was successful in preventing delirium, 
but once delirium occurred, the intervention did not improve the severity of delirium or the likelihood of 
a subsequent episode.29  
 
Nurses identified several facilitators within the CFIR domain “process” and construct “engaging”. First, 




preparation but felt more was needed. The QI team responded by presenting the evidence for cognitive 
stimulation as well as the QI project progress at MICU staff meetings and identifying a dedicated MICU 
occupational therapist who engaged the nurses in additional training. Moreover, nurse members (MG, 
SY) of the QI team incorporated the following education into the next round of super-user training: 
evidence supporting cognitive stimulation, creative ways to engage patients in cognitive stimulation, 
and proper documentation. The nurse super-users also conducted real-time audits and gave immediate 
feedback, which included further education as needed. This iterative approach to implementation, 
including sharing of evidence to support the intervention and feedback on performance measures, is an 
important but often overlooked aspect of translating evidence into practice.16,20 Second, the nurses 
suggested several ways to incorporate cognitive stimulation into their daily workflow. As part of the QI 
planning process, members of the multidisciplinary QI team directly observed nurses who were found to 
have very little time for additional tasks.30 Thus, incorporating cognitive stimulation into the nurses’ 
patient care routine is essential for successful implementation. The most commonly suggested strategy 
for doing so was to administer and document cognitive stimulation with sedation (Richmond Agitation 
Sedation Scale) and delirium (CAM-ICU) assessments.  
 
The nurses recognized the importance of culture change for successful implementation of an evidence-
based intervention in the ICU as has been demonstrated for both implementation of early mobility31 and 
recognizing and preventing delirium in the ICU.32 The recently updated SCCM PADIS Guidelines support 
the use of multicomponent, non-pharmacologic interventions, including cognitive stimulation, as 
evidence-based strategies to manage delirium in the ICU.12  
 
Our study had several limitations. First, there are several potential sources of bias in this qualitative 




themes by at least two independent reviewers with discrepancies resolved by group consensus with a 
third independent reviewer. Also, in order to further assess the reliability of our data, we performed 
member checking whereby we elicited feedback on themes from several MICU nurses. Second, we 
interviewed a subset of nurses from a single ICU, and so the emergent themes might not represent the 
views of nurses in other units. However, the aim of this investigation was to identify barriers to cognitive 
stimulation within the setting of a structured QI project in the [site de-identified]. Third, interviews were 
conducted during nurses’ shifts. However, interviewers offered to return during a more convenient 
time, if needed, and only one nurse requested the interviewer return during a less busy time. Moreover, 
the interviewers noted that nurses seemed eager to share their thoughts on the cognitive stimulation 
project. Finally, interviews were not recorded in order to maintain anonymity and encourage nurses to 
speak openly regarding their thoughts on the cognitive stimulation project. In place of transcribed 
interviews, interviews kept detailed field notes as described in the Methods Section. 
 
Conclusion 
Cognitive stimulation is an evidence-based method for delirium prevention. Implementation of cognitive 
stimulation requires addressing barriers that arise from attributes of the organization and context in 
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Chapter 4 – Section B Tables 
Table 1. Interview Guide 
1. What are your thoughts on the cognitive stimulation QI project that is currently  
     occurring in the MICU? 
2. What do you think are barriers to documenting whether or not the cognitive stimulation       
     packet was reviewed with patients? 
3. Probing: Can you give some examples of a time you did not document and why? 
4. What do you think are barriers to reviewing the cognitive stimulation packet with    
     patients? 
5. Probing: Can you give some examples of a time you did not review with a patient and   
    why? 























Table 2. Barriers to implementation of cognitive stimulation and the corresponding Consolidated 
Framework for Implementation Research domains and constructs 
Domain: Intervention Characteristics 
 
        Construct: Design Quality 
 
 Documentation - No designated section in electronic medical record 
 
Domain: Outer Setting 
 
        Construct: Patient Needs and Resources 
 
 Patient not cooperative/declines due to sedation, pain, agitation, fatigue, disinterest 
 
 Communication barriers (not English-speaking, visual or hearing impairment, restraints) 
 
 Family does not support cognitive stimulation 
  
Domain: Inner Setting 
 
        Construct: Relative Priority  
 
 Cognitive stimulation not a priority  
 
        Construct: Implementation Climate 
 
 Night shift not perceived as the appropriate time to do cognitive stimulation 
 
        Construct: Structural Characteristics 
 
 Nurse staff barriers (workload, staff turnover, lack of patient continuity) 
 
        Construct: Available Resources 
 
 Burden of documentation 
 
 Packet Availability 
 
Domain: Characteristics of Individuals 
 
        Construct: Knowledge and Beliefs about the Intervention 
 
 Lack of understanding of, or appreciation for, evidence for cognitive stimulation 
 
 Nurse perceives that patient will be offended because patient has high cognitive function 
 







Table 3. Facilitators to implementation of cognitive stimulation and the corresponding Consolidated 
Framework for Implementation Research domains and constructs 
Domain: Intervention Characteristics 
        Construct: Design Quality 
 Designated section in electronic medical record 
        Construct: Adaptability 
 Translate into other languages; have interpreter services at bedside 
 
 Consider using tablet or add more complex cognitive tasks to the packet for patients with 
higher cognitive function* 
Domain: Outer Setting 
        Construct: Patient Needs and Resources 
 Patient education on benefits of cognitive stimulation 
Domain: Inner Setting 
        Construct: Culture 
 Culture that supports research, quality improvement, and patient-centered care 
Domain: Characteristics of Individuals 
        Construct: Knowledge and Beliefs about the Intervention 
 Appreciation for importance of preventing delirium and benefits of cognitive stimulation 
Domain: Process 
        Construct: Engaging 
 Incorporating into work flow (add to daily task list and rounding report, administer with 
delirium assessment, checklist for cognition/delirium documentation; reminders (daily 
electronic reminders at 08:00 & 20:00)) 
 
 Education & training  











Table 4. Representative statements, extracted from field notes, by nurses regarding barriers to 
cognitive stimulation. 
Barrier Theme Field Note Extracts [Nurse ID]Ɨ 
Documentation - No 
designated section in electronic 
medical record 
In Epic*, there’s not a specific spot to document cog stim. You have 
to write it in as a comment. [001] 
There’s no specific box in Epic*. [004] 
Patient not 
cooperative/declines due to 
sedation, pain, agitation, 
fatigue, disinterest 
Some patients are angry at the world and I’m trying to interact as 
little as possible with them, and this is an easy thing to just not do. 
[003] 
If I can barely get their meds in (because they are refusing things), I 
doubt I can get them to do the packet. [010] 
The hard part is with patients who are sedated but it’s awesome for 
people who are awake and need a little push. [017] 
Communication barriers (not 
English-speaking, visual or 
hearing impairment, restraints) 
Patients who can’t use their hands might not be able to do it. If they 
can talk, they can at least answer me when I ask them the 
questions, but if they can’t use their hands or talk, they can’t do it. 
For example, this happens with patients who are restrained. [002] 
Visual acuity can be a problem – if they can’t see it. [009] 
We get a lot of Spanish speaking patients and we don’t have 
translators who are present in person. [014] 
Family does not support 
cognitive stimulation 
The patient’s family…they interfere with it, they give the patient the 
answer because they think they are helping or they don’t want us 
do it. [019] 
Cognitive stimulation not a 
priority 
Nurses don’t feel it’s crucial. [013] 
If I’m busy……..It’s lower in my priority list. [012] 
Somedays it’s hard to get to it. You know, it’s one more thing to 
add. [020] 
Night shift not perceived as the 
appropriate time to do 
cognitive stimulation 
I do it more during day shift than night. After 11P, I just want them 
to sleep. [010] 
We tuck them in, give meds, and treat symptoms. Night shift is a 
different culture. [021] 
Nurse staff barriers (workload, 
staff turnover, lack of patient 
continuity) 
I’m busy. We’re understaffed. [002] 
I can’t tell if it’s helping, if the patients are benefitting. We don’t 
have continuity so I don’t know from one day to the next if it’s 
helping. [002] 
I feel every couple of months there’s an additional task added 




Burden of documentation So much documentation that we have to go through, that little 
piece is sometimes missed. [008] 
We have to document so much, so sometimes it slips our minds. 
[016] 
Packet Availability People have written on them with permanent marker, and you 
have trouble finding a clean packet. [009] 
Lack of understanding of, or 
appreciation for, evidence for 
cognitive stimulation 
I think it’s just to validate something. I think the CAM-ICU is good 
enough. We don’t need to do more assessments. [022] 
I mean I see what the thought behind it is but our interaction is a 
better overall view. [018] 
For patients who are alert and oriented, it’s useless. [002] 
Nurse perceive that patient will 
be offended because patient 
has high cognitive function 
For patients who are a RASS of 0, they look at us like why are they 
making us connect the dots? [009] 
They look at me like ‘why am I doing this’ because they are alert 
and oriented. [001] 
Nurse not familiar with packet I’m sorry, I’m a travel nurse. Can you tell me about it? [015] 
[Lack of] familiarity or comfort. [004] 
*Epic is the electronic medical record. 
Ɨ Statements represents extracts from field notes and are not necessarily verbatim quotes 














Table 5. Representative statements, extracted from field notes, by nurses regarding facilitators for 
cognitive stimulation. 
Facilitator Theme Field Note Extracts [Nurse ID]Ɨ 
Designated section in electronic 
medical record 
If it had a separate section [in Epic*], it would be easier. 
[007] 
Dropdown list with the options would be helpful. [010] 
Translate into other languages; Have 
interpreter services at bedside 
We use translators through phones. It’s really hard for them 
to explain it over the phone…. [014] 
Consider using tablet or add more 
complex cognitive tasks to the packet 
for patients with higher cognitive 
function** 
Maybe it would be more appealing if you could use a tablet 
instead of a paper packet. [001] 
Patient education on benefits of 
cognitive stimulation 
It’s important to explain why you’re doing it. I say ‘we do 
this just to keep your brain active’. [009] 
Culture that supports research, 
quality improvement, patient-
centered care 
I’m used to doing research so I don’t mind doing anything to 
help patient care. [005] 
Appreciation for importance of 
preventing delirium and benefits of 
cognitive stimulation 
For some patients, it’s really helpful, especially in long-term 
sedated patients. It helps them recover from delirium. [014] 
Good benefits…could help patients. Help understand 
cognitive outcomes. [005] 
I’m for it. Anything that prevents delirium. [016] 
Incorporating into work flow (add to 
daily task list, add to rounding report, 
administer with delirium assessment, 
checklist for cognition/delirium 
documentation; reminders (daily 
electronic reminders at 08:00 & 
20:00)) 
Maybe it would be helpful if the documentation for the 
following could be done all at the same time and in the 
same location in Epic (i.e. the same flowsheet): AM-PAC, 
HLM, CAM, cognitive stimulation. [001] 
The best time to do the packet is probably with the second 
assessment of the day. For the first assessment, you’re just 
trying to catch up. After the first 4 hours, you’ve settled in. 
[004] 
We need a checklist to make sure all the nurses are being 
told where to document. [005] 
Education & training  There has been a lot of education – I’m surprised to hear 
that nurses aren’t documenting. [005] 




Abbreviations: AM-PAC – activity measure for post-acute care; CAM-ICU – Confusion Assessment 
Method for the ICU; JH-HLM – [site de-identified] Highest Level of Mobility Scale; RASS – Richmond-























CHAPTER 5: OVERALL THESIS CONCLUSIONS 
The overall goal of this thesis was to evaluate long-term complications of critical illness and evidence-
based methods for reducing such complications as part of implementation in routine clinical practice. 
In Chapter 2, I  synthesized the existing literature on early rehabilitaton in the intensive care unit to 
improve physical functioning and mental health outcomes for survivors of critical illness.  Building on 
this foundation of knowledge, in Chapter 3 (Section A), I conducted a systematic review and meta-
analysis focused on an important mental health outcome, posttraumatic stress disorder (PTSD), among 
survivors of critical illness.  This research demonstrated that approximately one in four survivors have 
clinically important PTSD symptoms at one year after critical illness. Risk factors for PTSD symptoms 
include benzodiazepine administration, mechanical ventilation, and post-ICU memories of frightening 
ICU experiences. PTSD symptoms are associated with worse quality of life. Based on existing published 
studies, there is limited evaluation of evidence-based interventions to address PTSD symptoms in this 
population. Further research is needed to address PTSD symptoms that commonly occur in survivors of 
critical illness. 
 
In Chapter 3 (Section B), we further evaluated the most common mental health symptoms experienced 
by survivors of critical illness via analyses of a prospective longitudinal cohort study of 698 ARDS 
survivors from 41 hospitals in the U.S. This research demonstrated that psychiatric symptoms occurred 
in two-thirds of survivors over 12 months after critical illness. Younger age, female sex, unemployment, 
alcohol misuse, and greater opioid use in the intensive care unit were associated with greater psychiatric 
symptoms, while traditional markers of severity of illness were not, a finding that is consistent with my 




survivors commonly have co-occurrence of symptoms of anxiety, depression and PTSD, suggesting that 
patient screening should consider each of these areas of mental health. 
 
In Chapter 4 (Section A), we conducted a pre-post evaluation of prospectively collected data involving 
ARDS patients. This evaluation demonstrated that more patients in the post-quality improvement (QI) 
vs. pre-QI group received physical therapy in the ICU and were able to stand, transfer or ambulate 
during physical therapy in the ICU. Patients in the post- vs. pre-group had a significantly shorter time to 
first active physical therapy intervention in the ICU, and this shorter time to intervention was sustained 
over 5 years following the QI project. Patients in the post- vs. pre-group also had a greater proportion of 
ICU days with physical therapy after initiation. During both the pre- and post-QI period, severity of 
illness and sedation were independently associated with a longer time to initiation of active physical 
therapy intervention. This evaluation demonstrates sustained improvement in the delivery of evidence-
based early rehabilitation via a structured quality improvement project.  
 
In Chapter 4 Section B, the focus was on the early stage of implementation of evidence-based cognitive 
stimulation to reduce delirium in the ICU.  This early stage investigation used qualitative methods to 
evaluate  barriers and facilitators to implementation cognitive stimulation, as part of routine clinical 
practice in a medical ICU.  Among 23 nurses providing semi-structured interviews, I identified 62 barriers 
to cognitive stimulation and 26 facilitators. The resulting themes (12 barrier and 9 facilitators) 
corresponded to the Consolidated Framework for Implementation Research (CFIR) domains: 
Intervention Characteristics, Outer Setting, Inner Setting, Characteristics of Individuals, and Process. 
Patient-specific variables (e.g. sedation) were the most frequently reported barriers to cognitive 
stimulation. Other barriers included: cognitive stimulation not a priority; staffing barriers; 





In conclusion, survivors of critical illness experience clinically important impairments in physical, 
cognitive and mental health that can last for years after discharge from the ICU and are associated with 
worse quality of life. Evidence-based interventions for prevention and treatment include early physical 
and cognitive interventions in the ICU. The use of structured quality improvement processes, including 
understanding potential barriers and facilitators to implementation, can play an important role to 
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Study type N Inclusion (I) and exclusion (E) criteria 
Male 
(%) 























I:  Age>16 yrs, medical & surgical ICU, required 
intubation & expected to receive MV ≥12 hrs 
E:  Neurologic conditions with expected best d/c 
GCS≤8, neuromuscular disease requiring 
ventilatory support, creatinine >2.0 mg/dL or 
requiring renal replacement therapy, allergy to 
benzodiazepines or morphine, epilepsy, drug 
overdose, liver failure class Child-Pugh C,  
pregnancy, mental disability or inability to 






































I: Age≥18 yrs, general ICU LOS ≥24hrs 
E: Died prior to hospital d/c, unable to give 
consent, lost to follow up, refused consent, stayed 






















I:  Age≥18 yrs,  ICU LOS ≥48 hrs 
E:  English difficulties, dementia or learning 
disabilities, self-inflicted injury/overdose 
(psychological comorbidity),  unable to consent in 







































I: Age>18 yrs; medical, surgical & trauma ICU; ICU 
LOS ≥24 hrs; could speak, read, & write English 
E:  Transferred from the ICU because of  expected 
death, d/c to home or another health care facility, 






















I:  MV ≥24 hrs, ICU LOS ≥72 hrs 
E:  Too confused to give informed consent, 
































I: Age 18-75 yrs; general, medical & CCU; ICU 
LOS   ≥24 hrs 
E:  Language difficulties, serious psychiatric 


















I: Age>18 yrs, general ICU LOS ≥ 24 hrs 
E: History of mental illness, history of head 






















I: Age>18 yrs, MV, general ICU LOS ≥24 hrs 
E: Head injury, psychotic illness, mental 
retardation, intoxication, admitted following 
suicide attempt, hearing/speech disability, 
non-Swedish speaking, transferred to another 
















I: MV, mixed general ICU LOS ≥48 hrs 
E: Burn injury, neurosurgical patient, 
preexisting psychotic 
illness, speech/reading difficulty, life 


























Study type N Inclusion (I) and exclusion (E) criteria 
Male 
(%) 




















I: Adult patients, MV for >36 hrs, medical & 
surgical ICU 
E: Craniotomy, coma, life support withdrawal, pre-
ICU psychosis, on ventilator at other hospital >3 d, 
difficult communication, cognitive impairment, 















I: Age>18 yrs , MV, mixed general ICU LOS ≥ 48 hrs 
E: Prior PTSD, admitted following suicide attempt, 
preexisting or concomitant psychotic illness, 
resides >30 km from hospital, unresolved 








































I: General medical ICU LOS ≥3 d, Age>18 yrs  
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I: Age > 18 yrs, ICU LOS ≥24 hrs, stayed on MV 
E:  Known pre-existing mental or terminal illness; 
admission for attempted suicide; inability to 
speak; neurologic deficit after ICU d/c; did not 

















I:  Patients d/c from surgical, medical & general 
ICU, ICU LOS ≥4 d or patients with shorter ICU stay 



















I: General ICU LOS ≥ 72 hrs 
E: Major medical or surgical therapy following 
d/c, reluctance to undergo detailed testing, 
























I: Age>18 yrs, medical ICU, required MV for 
>12 hrs 
E: Post-cardiopulmonary arrest, continuous 
MV >2 wks, moribund state  and/or life 
support withdrawal, profound neurological 
deficits that prevented independent living, 
enrollment in another trial, underwent 
cardiac surgery or neurosurgery, or stroke 








    68b 
(56-
76) 






































I: Age≥18 yrs, ICU care during hospital stay, 
surviving until hospital d/c 
E: Not expected to survive to leave hospital, 
unable to complete questionnaires or attend 





































9 (10)  
 
 
6 (8)  
 















I: Medical-surgical ICU, ICU LOS ≥4d 
E: Died on ICU day 4, not fluent in French, 
dementia,  unwillingness of family to 



























Study 1st author Study type N Inclusion (I) and exclusion (E) criteria 
Male 
(%) 























I: Age > 16 yrs, ICU LOS > 24 hrs, 
E: Being transferred to other centers, 
coronary artery disease, traumatic brain 
injury, foreigners,  known pre-existing 










- - 12 




I: General ICU survivors 
E: Head trauma, accidental or non-
accidental injury, admitted for routine 







- [1-33] - - 
13 (6) 
[3–21] 







I:  Age≥16 yrs, ICU LOS ≥ 96 hrs. 














































I: Age >18 yrs; anticipated MV >48 hrs 
E: pre-existing neurologic disease; pre-
existing end-stage liver & renal failure; 
second period of MV during hospitalization; 
MV >24 hours before ICU transfer; drug 





















































Study type N Inclusion (I) and exclusion (E) criteria 
Male 
(%) 























I: Medical & Surgical ICU; ICU LOS >24 hrs  
E: Admission diagnosis of traumatic injury or 
suicide attempt; pre-existing cognitive 
impairment or dementia; 
communication/language barrier; pre-existing 





















I: Adult ICU patients with acute respiratory 





























I: General adult ICU patients requiring MV 
>24hrs or ≥2 organs supported 
E: non-English speaking; pre-existing 
dementia; remained confused or had low 
Glasgow Coma Scale until ICU discharge; had 





27 (239) 8 (85) 3 (80) 22. (7) 3 





I: Included in the Evaluation of Psychoactive 
Medications in the Intensive Care Unit (EPIC) 
study 
E: No proxy available for information; death 
before the proxy interview; transferred from 
another ICU; admission <24 hours; non–
English speaking. 











I:  Age ≥18 yrs; medical & surgical ICU; 
required intubation & MV >24 hrs 
E:  Pregnancy; increased intracranial pressure; 
sedation indicated for medical diagnosis (e.g., 
































I:  Age ≥18 yrs; general ICU; MV & sedation 
>12 hrs 
E: Intracranial pathology; family history of 
malignant hyperthermia; dialysis at inclusion; 
























I: Age 18-65 yrs; treatment duration ≥ 24 h 
E: - 









I: ICU stay >24hrs, required MV 
E: Admission diagnosis of suicide attempt or 
















I: Medical & coronary care ICUs; MV 
E: Neurological disease impairing cognitive 
function or mental retardation; 
communication barrier because non-English 


















          APACHE II indicates acute physiology and chronic health evaluation II score; CCU, coronary care unit; CPR, cardiopulmonary resuscitation; d, days; d/c,     
         discharge; HIV, human immunodeficiency virus; hrs, hours; ICU, intensive care unit; LOS, length-of-stay; m, months; MV, mechanical ventilation; NIV, non- 
         invasive ventilation; PTSD, posttraumatic stress disorder; SAPS simplified acute physiology score; wks, weeks; yrs, years; -, not reported.  
 
a = Intervention group 
b = Control group   
c = APACHE III score 
d = Values of patients in one of two hospitals, from which most patients were recruited. 
e = hospital length of stay in addition to ICU length of stay 
f = No treatment limitations 
g = Do not intubate 
h = randomized to receive isoflurane 


























             Table 2:  Measurements of PTSD symptoms/PTSD diagnosis, ordered by follow-up time 












































































Wallen et al.35 - IES-R 1 100 18 (13) 
 
≥33 13% 






22 [14-84]a, 25 [13-65]b 






















































































Jones et al.22 - IES 2 
6 
63a, 51b, 114 



















































Jones et al.42 24% PDS 3 238 - DSM-IV 
criteria 
  9% 
Cuthbertson 
et al.43 





TSQ 3 108 - 6 52% 












> 20 & 
≥33 
14% & 5% 










23 (16)  
 
19 (14)  





















22 (12-29)a, 20 (14-26)b 























16 (16)a, 19 (17)b 
12 (14)a, 15 (16)b 
14 (14)a, 17 (15)b 
10 (14)a, 12 (13)b 
- - 
Van Der 






















Orgeas et al.14 
22%  
 













Scragg et al.24 - IES 
 
13e 77 - 30 16% 
Schandl et al.32 16%  IES 14 171 18a, 19b - - 





















42% DTS 21 (3) 48 24 (4) 40 25% 



































Wade et al.27 16% PDS 3 100 - 18 27% 






DSM-IV indicates Diagnostic and Statistical Manual of Mental Disorders – 4th Edition; DTS-I, Davidson Trauma Scale-Incidence subscale; DTS-S 
indicates Davidson Trauma Scale-Severity subscale; IES-A indicates Impact of Events Scale–Avoidance Subscale; IES-I, Impact of Events Scale–
Intrusion Subscale; IES-H, Impact of Events Scale–Hyperarousal Subscale; IES-R, Impact of Events Scale-Revised; n/a, not applicable; PCL, 
Posttraumatic stress disorder Checklist; PCL-C, Posttraumatic stress disorder Checklist – Civilian Version; PDS, Posttraumatic Diagnostic Scale; 
PTSD, posttraumatic stress disorder; PTSS-10, Posttraumatic Symptom Scale-10; PTSS-14, Post Traumatic Symptom Scale-14; SCID, Structured 
Clinical Interview for DSM-IV; TSQ, Trauma Stress 
Questionnaire;  -, not reported. 
 
a = Intervention group 























21  (17-25) 
a 









































Jones et al.53 15.6% IES 2 45 - - - 




c = Clinically significant symptoms of intrusion (I) or avoidance (A) 
d = Values of three groups namely no memory, without illusion memories and with illusion memories groups respectively 
e = Cross-sectional study with mean (SD) follow up of 13 (6) months and range of 13-21 months 
f = Prospective study with mean (SD) follow up of 35 (14) months 
g = Prevalence including both full PTSD-diagnosed patients and sub-syndromal PTSD-diagnosed patients 
h = Prevalence of full PTSD-diagnosed patients and sub-syndromal PTSD-diagnosed patients respectively 
i = Prevalence based on total of 61 patients completing the PTSD symptom assessment over the 12 month follow-up period 
j = no treatment limitation decisions 




Table 3. Risk of bias assessment for randomized controlled trials. 
Based on Cochrane criteria for assessing risk of bias in randomized controlled trials. “+” means Cochrane 
criteria met (i.e., low risk of bias). “-“ means Cochrane criteria not met (i.e., high risk of bias). “?” means 



























































































































Cuthbertson et al.20 + - - + + + 
Jones et al.22 + + + - ? + 
Jackson et al.21 + + - + + + 
Treggiari et al.19 + + - + ? + 
Jones et al.13 + - - + ? + 
Strom et al.18 + + - - + + 




Table 4. Risk of bias assessment for observational studies, based on the Newcastle Ottawa Scale 
Legend:  * = low risk of bias; ? = unclear risk of bias; blank = high risk of bias; + study controlled for type 




















































































































































































Rattray34 * * * * + * * * 
Perrins39   * * + * *  
Samuelson40 * * * * ++ * * * 
Jones42 * * * * + * * * 
Cuthbertson43 * * * * + * * * 
Griffiths44 * * * * + * * * 
Sukantarat47 * * * * + * *  
Rattray51 * * * * + * * * 
Twigg33 * * * * + * *  
Wallen35 * * * * ++ * * * 
Myhren38 * * * * ++ * * ? 
Myhren37 * * * * ++ * * * 
Myhren36 * * * * ++ * * * 
Weinert41 * * * * + * * * 
Schandl46 * * * * + * * * 
Granja48 * * * * ++ * * * 
Garrouste-Orgeas14 * * * * + * *  
Schandl32 * * * * ++ * * * 
Richter50 * * * * + * * * 
Bugedo31 * * * * + * *  
Davydow29 * * * * ++ * * * 
Davydow30 * * * * ++ * * * 
Azoulay28 * * * * + * *  
Wade27 * * * * ++ * * * 
Van Ness52 * * * * ++ * *  
Jones53 * N/A * ? N/A * * N/A 
Van der Schaaf23† * * * * ++ * * N/A 
Da costa45 * * * * + * *  
Badia-Castello49 * * * * ++ * *  
Girard54 * * * * ++ * * * 
Nickel25† * * * * + * * N/A 
Scragg24† * * * * ++ * * N/A 




                 Table 5: Potential risk factors for PTSD  
Study 
(n) 
Measure of  
association 
Potential risk/protective factor Outcome: post-traumatic stress symptoms/disorder 
Treggiari 





Light vs. deep sedation Normalized PTSD  score, mean ranks:  46 (29)a vs. 56 (29)b,  p = 
0.07 
Presumptive PTSD diagnosis:  9%a vs. 10%b, p = 0.83 
Rattray 








(a) Awareness of surroundings 
 
 
(b) Frightening experiences 
 
 
(c) Recall of ICU experiences 
 
 
(d) Satisfaction with ICU care  
 
(a) rho = -0.046 (IES-A) and -0.038 (IES-I) at d/c, n.s. 
      rho = -0.043 (IES-A) and 0.007 (IES-I) at 6 m, n.s. 
      rho = -0.095 (IES-A) and -0.030 (IES-I) at 12 m, n.s. 
(b) rho = 0.515 (IES-A) and 0.600 (IES-I ), p < 0.01 for both at d/c 
      rho = 0.458 (IES-A) and 0.437 (IES-I), p < 0.01 for both at 6 m 
      rho=0.470 (IES-A) and 0.413 (IES-I), p < 0.01 for both at 12 m 
 (c) rho =-0.354 (IES-A), p<0.01 and -0.263 (IES-I ), p< 0.05 at d/c 
      rho=-0.275 (IES-A) and -0.302 (IES-I), p < 0.05 for both at 6 m 
      rho = -0.193 (IES-A) and -0.121 (IES-I) at 12 m, n.s.  
(d) rho = -0.134 (IES-A) and -0.080 (IES-I) at d/c, n.s. 
      rho = -0.035 (IES-A) and -0.026 (IES-I) at 6 m, n.s. 
      rho = -0.127 (IES-A) and -0.039 (IES-I) at 12 m, n.s. 
Rattray 









(a) Time since hospital d/c (d/c, 6 m, 12 m) 
 







(d) APACHE II score  
(e) ICU LOS  
(f) Hospital LOS  
(g) Awareness of surroundings in ICU    
(hospital d/c) 
(h) Frightening ICU memories (hospital d/c) 
 
IES scores (square root) 
(a) 2.4 vs. 2.1 vs. 2.4 (IES-A), p = 0.34 
      2.7 vs. 2.4 vs. 2.6 (IES-I), p = 0.42 
(b) n.s. 
(c) rho = −0.25 with IES-A at hospital d/c, p = 0.02 
      rho = −0.38 with IES-A at 6 m, p = 0.003 
      rho = −0.33 with IES-A at 12 m, p = 0.003 
      rho = −0.41 with IES-I at hospital d/c, p = 0.0002 
      rho = −0.27 with IES-I at 6 m, p = 0.04 
      rho = −0.32 with IES-I at 12 m, p = 0.004 
(d) n.s. 
(e) rho = 0.26 with IES-I at 12 m, p = 0.02 
(f) rho = −0.25 with IES-I at hospital d/c, p = 0.02 
(g) n.s. 
 
(h) rho = 0.43 with IES-A at hospital d/c, p < 0.0001 







Measure of  
association 













(i) Satisfaction with ICU care (hospital d/c) 
(j) Recall of ICU experience (hospital d/c) 
(k) IES-A at hospital d/c  
 
(l) IES-I at hospital d/c 
 
      rho = 0.47 with IES-A at 12 m, p < 0.0001 
      rho = 0.53 with IES-I at hospital d/c, p < 0.0001 
      rho = 0.39 with IES-I at 6 m, p = 0.002 
      rho = 0.41 with IES-I at 12 m, p = 0.0002 
(i) n.s. 
(j) rho = -0.29 with IES-I at hospital d/c, p = 0.009 
(k) βst = 0.42 with IES-A at 6 m, p = 0.001; 
      βst = 0.19 with IES-A at 12 m, p = 0.10 
(l) βst = 0.46 with IES-I at 6 m, p = 0.001; 
     βst = 0.50 with IES-I at 12 m, p ≤ 0.0005 
Wallen 






(a) Age<65 yrs 
 
(b) Sex (male) 
(c) APACHE II score   
(d) ICU LOS 
(e) Emergency admission 
(f) Hospital LOS 
(a) Multivariate: OR 5.63 (1.17-26.89), p = 0.03 
Univariate 
(b) OR 1.39 (0.42-4.64), p = 0.59 
(c) OR 0.87 (0.77 to 0.98), p = 0.02 
(d) OR 0.99 (0.98-1.01), p = 0.20 
(e) OR 0.94 (0.24-3.75), p = 0.93 
(f) OR 0.79 (0.54-1.14), p = 0.20 
Jones 
et al. (n 
= 
352)13 
Fisher’s exact test 
Mann-Whitney U  





(b) Recalling delusional memories 
(c) ICU diary 
(a) p = 0.92, n.s. 
(b) p = 0.013 
(c) Median PTSS-14:  24a vs. 24b, n.s. at 3 m 
      New-onset PTSD:  5%a vs. 13%b, p = 0.02 at 3 m 
      Median change in PTSS-14 (for group with a baseline 
score ≥45): -23a vs. -2b, p = 0.04 
Myhren 






(b) Employment status 
(c) Respirator treatment 
(d) Life orientation test 
(e) Pain memories 
(f) Lack of control 
(g) Unable to express needs 
(h) Gender 
 
(a) β = 0.17, p = 0.007  
(b) β = 9.02, p < 0.001  
(c) β = 7.07, p = 0.004  
(d) β = -0.87, p < 0.001  
(e) β = 2.19, p = 0.004  
(f) β = 3.18, p < 0.001  
(g) β = 2.00, p = 0.012  








Study (n) Measure of  
association 
Potential risk/protective factor Outcome: post-traumatic stress symptoms/disorder 
Myhren et 





(a) Type of disease 
(b) Education 
(c) Personality trait (pessimism) 
(d) Pain memories 
(e) Factual memories 
Risk factors for delayed PTSD 
(a) Unemployment 
(b) ICU LOS 
(c) MV 
(d) Personality trait (optimism) 
(a) n.s. 
(b) OR 0.38 (0.15 to 0.95), p = 0.038 
(c) OR 0.91 (0.84 to 0.99), p = 0.029 
(d) OR 1.46 (1.05 to 2.04), p = 0.025 
(e) OR 6.61 (1.41 to 31.0), p = 0.017 
 
(a) OR 3.1 (1.1 to 8.7), p = 0.035 
(b) OR 1.1 (1.0 to 1.1), p = 0.005 
(c) OR 0.3 (0.1 to 0.8), p = 0.014 
(d) OR 1.1 (1.0 to 1.3), p = 0.028 
Perrins et 







(a) Sex  
(b) Trauma  
(c) Respiratory failure 
(d) No recall of the ICU 
(e) Lack of social support  
(f) Admitted to ICU via ED 
(g) Admitted conscious from a ward to ICU 
(a) n.s. 
(b) High IES and IES-A scores at 6 weeks, p < 0.05 
(c) High IES score at 6 weeks, p < 0.05 
(d) n.s. 
(e) n.s. 
(f) High IES score at 6 weeks, p < 0.05 
(g) High IES-A scores at 6 weeks, p < 0.02 
Samuelson 




Mann-Whitney U or 




(a) Younger age  
(b) Female sex  
(c) APACHE II  
(d) ICU LOS  
(e) Days of MV 
(f) Propofol in ICU  
(g) Midazolam in ICU  
(h) Ketobemidone in ICU  
(i) Neuromuscular blocker in ICU  
Proportion of total ICU stay with MAAS score… 
(j) …0–2  
(k) …3  
(l) …4-6  
(m) Complete amnesia of ICU 5 d post-ICU 
Comparisons: PTSD vs. no PTSD 
(a) Mean 57 vs. 64 yrs, p = 0.04 
(b) 74% vs. 46%, p = 0.04 
(c) Median 13 vs. 18, p = 0.09 
(d) Median 2.7 vs. 3.6, p = 0.42 
(e) Median 1.8  vs. 1.6, p = 0.97 
(f) 95% vs. 93%, p = 1.00 
(g) 68% vs. 30%, p = 0.02 
(h) 79% vs. 82%, p = 0.76 
(i) 5% vs. 13%, p = 0.71 
 
 
(j) Median 22% vs. 27%, p = 0.66 
(k) Median 62% vs. 67%, p = 0.48 
(l) Median 11% vs. 0%, p = 0.06 








Measure of  
association 




















(n) “Delusional memories” of ICU 5 d post-ICU 
(o) “Delusional memories” of ICU without factual 
recall 5 d post-ICU 
(p) No. of recalled extremely stressful events 5 d 
post-ICU 
(q) Recall of feeling fearful in ICU 5 d post 
      ICU 
(r) Nightmares 5 d post-ICU 
(s) HAD anxiety score 5 d post-ICU 
(t) HAD depression score 5 d post-ICU 
(u) Female sex  
(v) MAAS score 4-6  
(w) Recall of greater number of extremely 
       stressful events 5 d post-ICU 
(x) Female sex  
(y) MAAS score 4–6  
(z) Recall of feeling fearful in ICU 5 d post 
      ICU 
(n) 42% vs. 33%, p = 0.57 
 
(o) 0% vs. 3%, p = 1.00 
 
(p) Median 3 vs. 1, p = 0.03 
 
(q) 37% vs. 8%, p = 0.001 
 
(r) 16% vs. 13%, p = 0.72 
(s) Median 5 vs. 2, p = 0.006 
(t) Median 7 vs. 4, p = 0.001 
(u) OR = 4.7, p = 0.005 
(v) OR = 1.74 per 0.1 higher MAAS, p = 0.005 
(w) OR = 1.1, p = 0.008 
 
(x) OR = 4.9, p = 0.004 
(y) OR = 1.77 per 0.1 higher MAAS, p = 0.005 
(z) OR = 7.0, p = 0.002 
 
Jones et 
al. (n = 
102)22 
One-way ANOVA 
Fisher's exact test 
(a) No self-help rehabilitation manual  
(b) “Delusional memories” of ICU 2 w after ICU 
d/c  
(a) p = 0.026 at 8 w, n.s. at 6 m 
(b) 60% vs. 28% (PTSD vs. no PTSD), p = 0.028 
Weinert 
et al. (n 
= 149)41 




(a) Delirious vs. no delirious memories  
 
 
(b) Female sex 
(a) Mean PTSD-like  severity score: 7 (8) vs. 5 (6), p = 
0.018 at 2  m  
     PTSD diagnosis: 19% vs. 14%, n.s.  
(b) OR 2.2 (0.9-5.2), n.s. 
Jones et 









(a) Previous psychiatric history  
(b) Amount of sedation in ICU  
(c) Amount of opiates in ICU  
(d) Physical restraint in ICU  
(e) Mean hours restrained in ICU  
(f) “Delusional memories” of ICU 
      2 w post-ICU 
(a) rho = 0.23, p = 0.0003 
(b) rho = 0.15, p = 0.02 
(c) rho = 0.28, p < 0.0001 
(d) rho = 0.33, p < 0.0001 
(e) rho = 0.19, p = 0.003 







Study (n) Measure of  
association 
Potential risk/protective factor Outcome: post-traumatic stress 
symptoms/disorder 
Cuthbertson 
et al. (n = 78)43 







(a) Admission diagnosis; patient concern 
regarding severity/likelihood of death from 
critical illness/injury; sex; ICU LOS; APACHE II 
score 
(b) Age   
(c) Saw physician for mental health pre-ICU 





(b) 49 vs. 62 yrs (PTSD vs. no PTSD), p = 0.04 
(c) p = 0.005 
(d) p = 0.01 
Costa et al. (n 
= 90)45 
 




(b) Age ≤ 50 yrs 
(c) Cause of admission 
(d) Time in the ICU 
(e) Sedation received in the ICU 
(f) Duration of sedation 
(g) Level of sedation 
(h) ICU memories 
(i) Type of memories 
(i.1) No memory 
(i.2) Factual memories 
(i.3) Illusive memories 
(i.4) Factual and illusive memories 
(j) Duration of MV 
Comparisons: PTSD vs. no PTSD 
(a) 55% vs. 71%, p = 0.15 
(b) 95% vs. 75%, p = 0.05 
(c) p = 0.54 
(d) p = 1.00 
(e) 65% vs. 67%, p = 0.82 
(f) p = 0.68 
(g) p = 0.34 
(h) 80% vs. 75%, p = 0.72 
(i) p = 0.44 
(i.1) 20% vs. 24% 
(i.2) 30% vs. 43%  
(i.3) 0.0% vs. 3%  
(i.4) 50% vs. 30%  
(j) p = 0.50 
Schandl et al. 
(n = 30)46 
Repeated measures 
ANOVA  
or Friedman test or 
Student’s T-test or 




(b) APACHE II score, Trauma, Gender, ICU    LOS, 
Charlson Comorbidity Index 
(a) Mean age: 46 (17) vs. 57 (18) yrs (IES > 25 vs. 




et al. (n = 51)47 
Spearman's 
correlation 







Study (n) Measure of  
association 
Potential risk/protective factor Outcome: post-traumatic stress symptoms/disorder 
Jackson et 




Spontaneous awakening trial p = 0.83, at 3 m 
p = 0.60, at 12 m 







(a) Age, Sex, Employment status, Previous health 
status, SAPS II, ICU LOS, Diagnostic category 
(b) ICU memory tool 
(b.1) Not remembering the hospital stay  before 
ICU admission 
(b.2) Intrusive memory from hospital stay 





(b.1) OR 2.59 (CI - 1.22 to 5.47) 
 
(b.2) OR 3.83 (CI - 1.80 to 8.16)  
(b.3) Median PTSS-14: 37 (21-51) vs. 27 (18-38), p = 0.007 
(delusional  & factual memories vs. delusional & no 
factual memories) 
Cuthbertson 






Nurse led follow up clinic Mean DTS-I at 6 m: 16 (16)a vs. 19 (17)b, p = 0.07 
Mean DTS-I at 12 m: 12 (14)a vs. 15 (16)b, p = 0.05 
Mean DTS-S at 6 m: 14 (14)a vs. 17 (15)b, p = 0.10 
Mean DTS-S at 12 m: 10 (14)a vs. 12 (13)b, p = 0.37  
Garrouste-
Orgeas et al. 




















(a) ICU diary 
 
(b) IES-R scores in relatives  
(c) Gender (female) 
(d) Age 
(e) Antidepressant in past 3 m  
(f) Anxiolytic in past 3 m 
(g) Previous psychiatric admission 
(h) Previous psychiatric outpatient care 
(i) ICU LOS, Post-ICU hospital LOS, SAPS II, 
Logistic organ failure, Type of patient, Reason for 
admission 
(j) ICU care 
(j.1) Endotracheal tube 
(j.2) Epinephrine/norepinephrine 
Comparisons: PTSD vs. no PTSD 
 (a) Mean IES-R: 21 (12)a vs. 32 (15)b, p = 0.004  
      PTSD prevalence: 50%a vs. 69%b, n.s.  
(b) rho = 0.3, p = 0.02 
(c) 54% vs. 19%, p = 0.01  
(d) p = 0.4 
(e) 14% vs. 5%, p = 0.4  
(f) 23% vs. 9%, p = 0.2  
(g) 9% vs. 9%, p = 0.2  





(j.1) 77% vs. 48%, p = 0.016  






Study (n) Measure of  
association 
Potential risk factor Outcome: post-traumatic stress symptoms/disorder 
  (j.3) Dobutamine 
(j.4) Dialysis 
(j.5) Central venous catheter 
(j.6) Arterial catheter 
(k) ICU stay events 




(l.4) Neuromuscular blockers 
(m) Peritraumatic dissociation score 
       (3 m post-d/c) 
(j.3) 11% vs. 0%, p = 0.3  
(j.4) 14% vs. 9%, p = 0.7  
(j.5) 63% vs. 48%, p = 0.3  
(j.6) 40% vs. 38%, p = 1.00  
(k) 20% vs. 19%, p = 1.00  
 
(l.1) 49% vs. 33%, p = 0.2  
(l.2) 66% vs. 38%, p = 0.051  
(l.3) 74% vs. 52%, p = 0.12  
(l.4) 49% vs. 24%, p = 0.09  
(m) p = 0.11  
Badia-Castelló 




or χ2 test 
(a) Female vs. male 
(b) No memory vs. without illusion memories 
vs. with illusion memories 
(a) Mean IES: 11 (14) vs. 4 (6), no p-value 
(b) Mean IES: 1 (6) vs. 6 (8) vs. 11 (12), p < 0.001 
Scragg 









Schandl (n = 
171)32 
Man-Whitney 
U or  Logistic 
quantile 
regression  
(a) Females vs. males 
(b) Females in ICU follow up vs. control 
(c) Males in ICU follow up vs. control 
(d) Males  
(e) Psychiatrist evaluation and treatment  
(e.1) Females 
(e.2) Males 
(a) Median IES:  24.5 vs. 13, p < 0.01c  
(b) Median IES:  20a vs. 31b, p = 0.01 
(c) Median IES:  16a vs. 10b, p = 0.27 
(d) n.s. 
 
(e.1) Median IES n = 6, 35 vs. 21 (3 m vs. 14 m), p < 0.05 
(e.2) Median IES n = 3, 28 vs. 10 (3 m vs. 14 m), p = 1.0 










(a) Age, APACHE II score, Injury severity  
score, ICU LOS, Time until follow up, 
Duration of ventilation, Duration of 
sedation, Traumatic brain injury, Previous 
psychiatric disorder 
(b) Additional psychiatric diagnoses at 













Study (n) Measure of  
association 
Potential risk factor Outcome: post-traumatic stress symptoms/disorder 









(a) recall of traumatic memories 
(b) benzodiazepine use and dose 
(c) analgesia use and dose 
(d) NMB use and dose 
(e) level of sedation during mechanical 
ventilation 




















(a) traumatic events during adulthood 
 
(b)  previous psychiatric history 
 
(c) stressful life events 
(d) CES-D scores  
(e) sex 
(f) age 
(g) childhood traumatic events 
(h) social issues 
(a)  r=0.439, p=0.002; β=17.01, p=0.037; x2=3.692, 
p=0.055; OR=2.819, p=0.093 
(b) r=0.439, p=0.002; β=19.76, p=0.003; x2=11.429, 
p=0.001; OR=13.01, p=0.003 
(c) r=0.337, p=0.005; x2=5.333, p=0.023; OR=3.353, 
p=0.067 





Davydow et al. 





a) CRHBP A/T 
b) CRHBP T/T 
c) CRHR1 C/T 
d) CRHR1 C/C 
e) age 
f) non-white 
g) SAPS II 
h) in-ICU corticosteroid exposure 
a) β=-1,6 (-5.8, 2.6), p=0.44 
b) β=-11.1 (-17.8, -4.7), p=0.002 
c) β=4.0 (-8.4, 16.3), p=0.53 
d) β=0.2 (-12.3, 11.9), p=0.98 
e) β=-0.1 (-0.3, 0.02), p=0.09 






Study (n) Measure of  
association 
Potential risk factor Outcome: post-traumatic stress 
symptoms/disorder 
Davydow et al. 




(a) in-hospital substantial acute stress symptoms 





(g) marital status 
(h) lifetime history of major depression 
(i) alcohol use 
(j) drug abuse 
(k) associated comorbidities 
(l) mechanically ventilated 
(m) required major surgery 
(n) required blood product transfusion 
(o) in-hospital probable delirium 
(p) days of exposure to hospital exposure to BZD, 
opioids, antipsychotics, antidepressants 
(q) required physical restraints 
(a) β=17.3(95% CI: 12.1-22.4); p<0.001d 






















Azoulay et al. 
(n=154)28                                                                 
Wilcoxon rank-sum 
test
Pearson Chi Square 
Test 
Fishers exact test 











one-way ANOVA,   
 
(a) length of stay in ICU 
(b) length of hospital stay 
(c) type of admission 
(d) post hospital destination 
(e) primary body system 










Study (n) Measure of  
association 








(g) use of steroids 
(h) age 
(i) sex (female vs male) 
(j) ethnicity (white vs other) 
(k) socio-economic position 
(l) duration of sedation (days) 
(m) benzodiazepines (yes/no) 
(n) antipsychotics (yes/no) 
(o) ICU Mood 
(p) ICU intrusive memories 
(q) psychological history (yes/no) 
(r) Alcohol use (yes/no) 






(l) β=0.33 (-0.18, 0.84) 
(m) β=0.352, p=0.87 
(n) β=1.06, p=0.62 
(o) β=0.25, p<0.01 
(p) β=5.83,p<0.01 
(q) β=6.55, p<0.05 
(r) β=4.63, p=0.14 
(s) β=0.71, p=0.05 
Van Ness et al. 
(n = 152)52 
Kendall taub 
correlation matrix 
(a) ADL disability post-ICU 
(b) cognitive impairment post-ICU 
(c) delirium post-ICU 
(d) depression post-ICU 
(a) taub (standard error) = 0.20 (0.05), 
p<0.05 
(b) taub (standard error) = 0.18 (0.10), 
p>0.05 
(c) taub (standard error) = 0.11 (0.11), 
p>0.05 
(d) taub (standard error) = 0.26 (0.06), 
p<0.05 
Strom et al. (n 
= 26)18 
Two-sample T 
Test, χ2 test 
Sedation vs. no sedation PTSS-10  score > 35:  1(8%)a vs. 0 (0)b,  p = 
0.14 
Median (IQR) PTSS-10 score: 3 (0-6.5)a vs. 10 
(6-17)b, p=0.09 
IES-R score > 32: 1(8%)a vs. 2 (15%)b, p=0.50 
Median (IQR) IES-R score: 4 (2-8)a vs. 2 (0-
11)b, p=0.41 





Fisher’s exact test  
(a) isoflurane sedation vs. Midazolam sedation 
(b) number of encircled memories of feelings 
(c) memories of negative feelings from ICU 
(d) memories of delusions from ICU 
(e) “real” memories from ICU 
(f) previous posttraumatic experiences 
(a) n.s. 
 
(b) rho=.82, p=.001 
 





Study (n) Measure of  
association 





et al. (n = 41)25 
Fischer’s exact test 
Mann-Whitney U 
(a) prior psychiatric disease 
(b) APACHE II 
 
(a) PTSD vs no-PTSD, p=0.025 
(b) n.s. 
Jones et al. (n 
= 45)53 
Kruskal wallis test 
Student’s t test 
Spearman’s 
correlation 
(a) diagnostic group 
(b) premorbid psychopathology 
 (c) no factual memories and delusions vs. no 
delusional memories at 2 weeks 
(d) anxiety at 2 weeks 
(e) anxiety at 8 weeks 





(d) rho=0.45, p=0.014 
(e) rho = 0.39, p=0.035 
(g) rho = 0.30, p=0.108 










(a) total dose of lorazepam 
(b) female vs. male gender 
 
(c) duration of delirium 
(d) APACHE II score 
(e) duration of mechanical ventilation 
(f) ICU LOS 
(g) Memories of traumatic ICU experiences 
(h) Composite neuropsychological test scores 
(i) age 
(a) β=0.39 for 10mg increase in lorazepam, 
p=0.001 
(b) β=7.36, p=0.02; median (IQR) PTSS-10 
score 22(16-35) vs, 17(12-27), p=0.06 
(c) n.s. 
(d) n.s. 
(e) rho=0.034, p=0.83 
(f) rho=0.10, p=0.51 
(g) rho=0.366, p=0.02 
(h) rho=-0.079, p=0.63 
 
(i) p=0.04 
ADL indicates activities of daily living; ANOVA, analysis of variance; APACHE II, Acute Physiology and Chronic Health Evaluation II Score; β, linear 
regression coefficient in multivariable model; βst, standardized linear regression coefficient in multivariable model; CES-D, Center for 
Epidemiologic Studies Depression Scale; CI, confidence interval; d, day(s); CRHBP, corticotrophin-releasing hormone binding protein; CRHR1, 
corticotrophin-releasing hormone receptor type 1; DTS-I indicates Davidson Trauma Scale-Incidence subscale; DTS-S indicates Davidson Trauma 
Scale-Severity subscale; d/c, discharge; “delusional memories,” memories of in-ICU psychotic/nightmare experiences; ED, emergency 
department; GCS, Glasgow Coma Scale; HAD, Hospital Anxiety and Depression Scale; IES, Impact of Events Scale; IES-A, Impact of Events Scale-
Avoidance Subscale; IES-I, Impact of Events Scale-Intrusion Subscale; IES-R, Impact of Events Scale-Revised; ICU, intensive care unit; LOS, length 




neuromuscular blockers; OR, odds ratio; P75, 75th Percentile; PTSD, posttraumatic stress disorder; PTSS-14, Post Traumatic Symptom Scale-14; 
rho, Correlation coefficient; SAPS II, Simplified Acute Physiology Score; SCL 90 R, Symptom Checklist-90-Revised; TISS, Therapeutic Intervention 
Scoring System; w, week(s); χ2, Chi-square test; yrs, years. 
 
a = Intervention group  
b = Control group 
c = Values updated after enquiring respective authors 
d = adjusted for patient characteristics 




Table 6. Associations of PTSD symptoms/PTSD diagnosis and Quality of Life 












Myhren  et al.     





12 IES SF-36 PF 
 
SF-36 MH 
β = -9.1 (-17.6 to -0.6),         
p < 0.05 (IES ≥20 vs. PF) 
β = -11.6 (-17.3 to -6.0), 
p < 0.001 (IES ≥ 20 vs. MH) 
Sukantarat et al. 


















                 
IES-I 
 
              
IES-A 
 











EQ-5D VAS  
SF-36 PCS  
SF-36 MCS  
rho = -0.34, p < 0.005 
rho = -0.28, n.s. 
rho = -0.34, p < 0.05 
rho = -0.24, p > 0.05 
rho = -0.06, n.s. 
rho = -0.38, p < 0.05 
rho = -0.50, p < 0.001 
rho = -0.23, n.s. 
rho = -0.48, p < 0.001 
rho = -0.50, p < 0.001 
rho = -0.16, n.s. 
rho = -0.49, p < 0.001 
Van Der Schaaf  
et al. (n = 238)23 
Spearman’s 
correlation  
12 IES SIP 68 rho = 0.260, p < 0.001 
Paparrigopoulos 
et al. 
(n = 48)26 
Spearman’s    
   correlation  
21(3) DTS SF-36 
SF-36 MH 
SF-36 PH 
r=-0.291, p < 0.05 
r=-0.610, p < 0.001 
n.s. 
Sackey et al.  
(n = 28)17 
Spearman’s  
   correlation 
17 IES Well-Being 
Index 
rho = -0.67, p < 0.005 
Girard et al. 
(n = 43)54 
Spearman’s  
   correlation 
6 PTSS-10 SF-12 rho=-0.565, p < 0.0001 
 
β indicates linear regression coefficient in multivariable model; DTS, Davidson Trauma Scale; EQ-5D VAS, 
Euro-Quality of life Visual Analogue Scale; IES, Impact of Events Scale; IES-A, Impact of Events Scale–
Avoidance Subscale; IES-I, Impact of Events Scale–Intrusion Subscale; n.s., not significant; PTSS-10, 
Posttraumatic Symptom Scale – 10; rho, Correlation coefficient; SF-12, Short Form-12; SF-36, Short 
Form-36; SF-36 MCS, Short Form-36 Mental Component Summary; SF-36 MH, Short Form-36 Mental 
Health; SF-36 PCS, Short Form-36 Physical Component Summary; SF-36 PF, Short Form-36 Physical 




The SF-36 and SF-12 have two overall summary measures known as the Mental Component Summary 
and the Physical Component Summary (norm-based score 0-100, with higher scores indicating better 
health-related quality of life (HRQOL)). EQ5D – scored 0-100 with higher scores indicating better HRQOL. 
SIP68 – scored 0-68 with higher scores indicating worse HRQOL. Well-being index – scored 0-30 with 





Chapter 4 – Section B Tables 
 
eTable 1. Consolidated Framework for Implementation Research (CFIR) domains and reported 
constructs as defined in Damschroder et al.* 
Domain 
       Construct 
Description 
Intervention Characteristics “Core components of the intervention itself and an adaptable 




“Degree to which an intervention can be adapted, tailored, refined 
or reinvented to meet local needs”  
 Design Quality “Perceived excellence in how the intervention is bundled, 
presented, and assembled” 
Outer Setting “Economic, political, and social context of the organization that an 
intervention occupies” 
 Patient Needs and 
Resources 
“Extent to which patient needs, as well as barriers and facilitators 
to meet those needs, are accurately known and prioritized by the 
organization” 
Inner Setting “Economic, political, and social context through which 
implementation process proceeds” 
 Culture “Norms, values and basic assumptions of a given organization” 
 Implementation 
Climate 
“Absorptive capacity for change, shared receptivity of involved 
individuals to an intervention, and the extent to which use of that 
intervention with be ‘rewarded, supported, and expected within 
their organization’.” 
 Relative Priority “Individuals’ shared perception of the importance of the 
implementation within the organization” 
 Structural 
Characteristics 
“Social architecture, age, maturity, and size of an organization” 
 Available Resources “Level of resources dedicated for implementation and ongoing 
operations including money, training, education, physical space, 
and time” 





 Knowledge and Beliefs 
about Intervention 
“Individuals’ attitudes toward and value placed on the intervention, 
as well as familiarity with facts, truths, and principles related to the 
intervention” 
Implementation Process “Interrelated sub-processes that aim to achieve individual and 
organizational level use of the intervention as designed” 
 Engaging “Attracting and involving appropriate individuals in the 
implementation and use of the intervention through a combined 
strategy of social marketing, education, role modeling, training, and 
other similar activities” 
 
* Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of 
health services research findings into practice: a consolidated framework for advancing implementation 























eTable 2. Consolidated criteria for reporting qualitative studies (COREQ): 32-item checklist 
Criteria Page 
Domain 1: research team and reflexivity 
Personal Characteristics 
1. Interviewer/facilitator Which author/s conducted the interview or focus group?  5 
2. Credentials What were the researcher's credentials? E.g. PhD, MD  5 
3. Occupation What was their occupation at the time of the study?  5 
4. Gender Was the researcher male or female?  5 
5. Experience and training What experience or training did the researcher have?  5 
Relationship with participants   
6. Relationship established 
Was a relationship established prior to study 
commencement?  
4-5 
7. Participant knowledge of 
the interviewer 
What did the participants know about the researcher? e.g. 
personal goals, reasons for doing the research  
3-4 
8. Interviewer characteristics 
What characteristics were reported about the 
interviewer/facilitator? e.g. Bias, assumptions, etc 
N/A 
Domain 2: study design  
Theoretical framework  
9. Methodological orientation 
and Theory  
What methodological orientation was stated to underpin 
the study? e.g. grounded theory, discourse analysis, 
ethnography, phenomenology, content analysis  
5 
Participant selection  
10. Sampling  
How were participants selected? e.g. purposive, 
convenience, consecutive, snowball  
4 
11. Method of approach  
How were participants approached? e.g. face-to-face, 
telephone 
4 
12. Sample size  How many participants were in the study?  7 
13. Non-participation  




14. Setting of data collection  Where was the data collected? e.g. home, clinic, workplace  4-5 
15. Presence of non-
participants  
Was anyone else present besides the participants and 
researchers?  
4 
16. Description of sample  
What are the important characteristics of the sample? e.g. 
demographic data, date  
7 
Data Collection 
17. Interview guide  
Were questions, prompts, guides provided by the authors? 






18. Repeat interviews  Were repeat interviews carried out? If yes, how many?  7 
19. Audio/visual recording  
Did the research use audio or visual recording to collect 
data?  
5 
20. Field notes  
Were field notes made during and/or after the interview or 
focus group?  
5 
21. Duration  What was the duration of the interviews or focus group?  7 
22. Data saturation  Was data saturation discussed?  6 
23. Transcripts returned  
Were transcripts returned to participants for comment 
and/or correction?  
11 Ɨ 
Domain 3: analysis and findings 
Data analysis  
24. Number of data coders  How many data coders coded the data?  6 
25. Description of coding tree  Did authors provide a description of the coding tree?  6 
26. Derivation of themes  
Were themes identified in advance or derived from the 
data?  
5-6 
27. Software  
What software, if applicable, was used to manage the 
data?  
N/A 
28. Participant checking  Did participants provide feedback on the findings?  6, 11 
Reporting 
29. Quotations presented  
Were participant quotations presented to illustrate the 
themes / findings? Was each quotation identified? e.g. 
participant number  
Tables 
5 & 6€ 
30. Data and findings 
consistent  
Was there consistency between the data presented and the 
findings?  
6-11 
31. Clarity of major themes  Were major themes clearly presented in the findings?  6-11 
32. Clarity of minor themes  




*Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item 
checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349-57.  
Ɨ Member checking was performed with nurses who were members of the multidisciplinary QI team 
€ Interviews were not transcribed verbatim. Representative statements were taken from detailed field 
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